<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73592</article-id><article-id pub-id-type="doi">10.7554/eLife.73592</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-253080"><name><surname>Verma</surname><given-names>Mayank</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0167-0842</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101387"><name><surname>Asakura</surname><given-names>Yoko</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4107-4236</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253081"><name><surname>Wang</surname><given-names>Xuerui</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253082"><name><surname>Zhou</surname><given-names>Kasey</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253083"><name><surname>Ünverdi</surname><given-names>Mahmut</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253084"><name><surname>Kann</surname><given-names>Allison P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0111-9081</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-138768"><name><surname>Krauss</surname><given-names>Robert S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7661-3335</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-53396"><name><surname>Asakura</surname><given-names>Atsushi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8078-1027</contrib-id><email>asakura@umn.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05byvp690</institution-id><institution>Department of Pediatrics &amp; Neurology, Division of Pediatric Neurology, The University of Texas Southwestern Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04jnprq39</institution-id><institution>Stem Cell Institute, University of Minnesota Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04jnprq39</institution-id><institution>Greg Marzolf Jr. Muscular Dystrophy Center, University of Minnesota Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04jnprq39</institution-id><institution>Department of Neurology, University of Minnesota Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Department of Cell, Developmental, and Regenerative Biology, Icahn School of Medicine at Mount Sinai</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Graduate School of Biomedical Sciencesf, Icahn School of Medicine at Mount Sinai</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cheung</surname><given-names>Tom H</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00q4vv597</institution-id><institution>The Hong Kong University of Science and Technology</institution></institution-wrap><country>Hong Kong</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cheah</surname><given-names>Kathryn Song Eng</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02zhqgq86</institution-id><institution>University of Hong Kong</institution></institution-wrap><country>Hong Kong</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>06</day><month>06</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e73592</elocation-id><history><date date-type="received" iso-8601-date="2021-09-02"><day>02</day><month>09</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2024-06-05"><day>05</day><month>06</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-08-28"><day>28</day><month>08</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.08.28.458037"/></event></pub-history><permissions><copyright-statement>© 2024, Verma et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Verma et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73592-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-73592-figures-v2.pdf"/><abstract><p>Endothelial and skeletal muscle lineages arise from common embryonic progenitors. Despite their shared developmental origin, adult endothelial cells (ECs) and muscle stem cells (MuSCs; satellite cells) have been thought to possess distinct gene signatures and signaling pathways. Here, we shift this paradigm by uncovering how adult MuSC behavior is affected by the expression of a subset of EC transcripts. We used several computational analyses including single-cell RNA-seq (scRNA-seq) to show that MuSCs express low levels of canonical EC markers in mice. We demonstrate that MuSC survival is regulated by one such prototypic endothelial signaling pathway (VEGFA-FLT1). Using pharmacological and genetic gain- and loss-of-function studies, we identify the FLT1-AKT1 axis as the key effector underlying VEGFA-mediated regulation of MuSC survival. All together, our data support that the VEGFA-FLT1-AKT1 pathway promotes MuSC survival during muscle regeneration, and highlights how the minor expression of select transcripts is sufficient for affecting cell behavior.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>skeletal muscle</kwd><kwd>muscle stem cell</kwd><kwd>VEGF</kwd><kwd>endothelial cell</kwd><kwd>Flt1</kwd><kwd>satellite cell</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIHT32-GM008244</award-id><principal-award-recipient><name><surname>Verma</surname><given-names>Mayank</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIHF30AR066454</award-id><principal-award-recipient><name><surname>Verma</surname><given-names>Mayank</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><award-id>AR070231</award-id><principal-award-recipient><name><surname>Krauss</surname><given-names>Robert S</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012636</institution-id><institution>New York State Stem Cell Science</institution></institution-wrap></funding-source><award-id>NYSTEM-C32561GG</award-id><principal-award-recipient><name><surname>Kann</surname><given-names>Allison P</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><award-id>NIHR01AR062142</award-id><principal-award-recipient><name><surname>Asakura</surname><given-names>Atsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><award-id>NIHR21AR070319</award-id><principal-award-recipient><name><surname>Asakura</surname><given-names>Atsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005202</institution-id><institution>Muscular Dystrophy Association</institution></institution-wrap></funding-source><award-id>MDA241600</award-id><principal-award-recipient><name><surname>Asakura</surname><given-names>Atsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100016944</institution-id><institution>Regenerative Medicine Minnesota</institution></institution-wrap></funding-source><award-id>RMM 092319 TR 010</award-id><principal-award-recipient><name><surname>Asakura</surname><given-names>Atsushi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Bulk and single-cell RNA-seq data demonstrated that muscle stem cells express low levels of canonical endothelial cell markers, including VEGFA receptors, and VEGFA-FLT1 pathway has a drastic effect on muscle stem cell survival through AKT1 in vitro and in vivo.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Skeletal muscle and endothelial cells (ECs) and their progenitors from the trunk and limbs are derived from the somites during early developments. Previous works demonstrated the existence of bipotent progenitors which express both <italic>Pax3</italic> and <italic>Flk1</italic> (<xref ref-type="bibr" rid="bib23">Eichmann et al., 1993</xref>; <xref ref-type="bibr" rid="bib40">Kardon et al., 2002</xref>; <xref ref-type="bibr" rid="bib24">Ema et al., 2006</xref>; <xref ref-type="bibr" rid="bib25">Esner et al., 2006</xref>; <xref ref-type="bibr" rid="bib84">Tozer et al., 2007</xref>). These bipotent progenitors migrate into trunk and limb buds from ventrolateral region of the somites to generate MYOD(+) myogenic cells followed by skeletal muscle and PECAM1(+) ECs followed by vasculatures (<xref ref-type="bibr" rid="bib38">Hutcheson and Kardon, 2009</xref>; <xref ref-type="bibr" rid="bib40">Kardon et al., 2002</xref>; <xref ref-type="bibr" rid="bib44">Lagha et al., 2009</xref>; <xref ref-type="bibr" rid="bib57">Mayeuf-Louchart et al., 2016</xref>; <xref ref-type="bibr" rid="bib56">Mayeuf-Louchart et al., 2014</xref>). In addition, FLK1(+) cells give rise to myogenic cells during development and oncologic transformation (<xref ref-type="bibr" rid="bib22">Drummond and Hatley, 2018</xref>; <xref ref-type="bibr" rid="bib56">Mayeuf-Louchart et al., 2014</xref>; <xref ref-type="bibr" rid="bib64">Motoike et al., 2003</xref>). Lastly, multipotent mesoangioblasts, vessel‐associated stem cells, have been identified in embryonic dorsal aorta (<xref ref-type="bibr" rid="bib60">Minasi et al., 2002</xref>). These cells are able to differentiate into several types of mesodermal tissues including skeletal muscle and ECs (<xref ref-type="bibr" rid="bib74">Roobrouck et al., 2011</xref>). Interestingly, these myogenic cells show the same morphology as muscle satellite cells (MuSCs), stem cell populations for skeletal muscle, and express a number of myogenic and EC markers such as <italic>Myod</italic>, <italic>Cdh15</italic>, <italic>Kdr,</italic> and <italic>Cdh5</italic> (<xref ref-type="bibr" rid="bib17">De Angelis et al., 1999</xref>). However, it is not clear whether adult MuSCs derived from these bipotent progenitors still maintain canonical EC signals. Curiously, blood vessel-associated myoendothelial cell progenitors that express both myogenic and EC markers, and are able to differentiate into myogenic cells following transplantation have been identified in the interstitial spaces of both murine and human adult skeletal muscle (<xref ref-type="bibr" rid="bib81">Tamaki et al., 2002</xref>; <xref ref-type="bibr" rid="bib103">Zheng et al., 2007</xref>; <xref ref-type="bibr" rid="bib37">Huang et al., 2014</xref>). However, the relationship between these myoendothelial cell progenitors and MuSCs remains unclear.</p><p>Vascular endothelial growth factor (VEGF), specifically VEGFA modulates many biological aspects including angiogenesis through its two receptors, FLT1 and FLK1. Although FLK1 possesses stronger signaling capability and the major signaling receptor tyrosine kinase (RTK) for VEGFA, FLT1 has considerably higher affinity for VEGF but weaker cytoplasmic signaling capability. In normal tissue, FLT1 acts as a decoy receptor and a sink trap for VEGF thereby preventing excessive normal and pathological angiogenesis. In addition, there are two co-receptors for VEGFA (NRP1 and NRP2) that function with FLK1 to modulate VEGFA signaling. While VEGF signaling has been extensively studied for its role in development, proliferation, and survival of endothelial cells (ECs), its role in non-vascular systems such as neuron and bone has only recently been appreciated (<xref ref-type="bibr" rid="bib73">Poesen et al., 2008</xref>; <xref ref-type="bibr" rid="bib51">Liu et al., 2012</xref>; <xref ref-type="bibr" rid="bib68">Okabe et al., 2014</xref>). Skeletal muscle tissue is the most abundant producer of VEGFA in the body. It has already been extensively studied in the skeletal muscle fibers in models of <italic>Vegfa</italic> knockout mice (<xref ref-type="bibr" rid="bib82">Tang et al., 2004</xref>; <xref ref-type="bibr" rid="bib95">Wagner et al., 2006</xref>; <xref ref-type="bibr" rid="bib69">Olfert et al., 2009</xref>) as well as <italic>Vegfa</italic> overexpression (<xref ref-type="bibr" rid="bib2">Arsic et al., 2004</xref>; <xref ref-type="bibr" rid="bib98">Yan et al., 2005</xref>; <xref ref-type="bibr" rid="bib59">Messina et al., 2007</xref>; <xref ref-type="bibr" rid="bib9">Bouchentouf et al., 2008</xref>).</p><p>Adult skeletal muscle also contains the tissue resident muscle stem cell population, termed MuSCs, which mediate postnatal muscle growth and muscle regeneration (<xref ref-type="bibr" rid="bib62">Motohashi and Asakura, 2014</xref>). After muscle injury, quiescent MuSCs initiate proliferation to produce myogenic precursor cells, or myoblasts. The myoblasts undergo multiple rounds of cell division before terminal differentiation and formation of multinucleated myotubes by cell fusion. Importantly, the MuSC-derived myoblasts also express VEGFA, which has been shown to increase the proliferation of myoblasts (<xref ref-type="bibr" rid="bib16">Christov et al., 2007</xref>). Our data obtained from genetical model mice demonstrated that MuSCs express abundant VEGFA, which recruits ECs to establish vascular niche for MuSC self-renewal and maintenance (<xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>). In addition, VEGFA and its receptors are expressed in the myoblast cell line, C2C12 cells, and the signaling can induce cell migration and protect apoptotic cell during myogenic differentiation in vitro (<xref ref-type="bibr" rid="bib30">Germani et al., 2003</xref>; <xref ref-type="bibr" rid="bib10">Bryan et al., 2008</xref>; <xref ref-type="bibr" rid="bib58">Mercatelli et al., 2010</xref>). However, it is not clear whether MuSCs also express VEGF receptors and if cell-autonomous VEGFA signaling plays an essential roles in MuSC function during muscle regeneration in vivo.</p><p>We have previously shown that <italic>Flt1</italic> heterozygous gene knockout and conditional deletion of <italic>Flt1</italic> in ECs display increased capillary density in skeletal muscle, indicating the essential roles for <italic>Flt1</italic> in adult skeletal muscle. More importantly, when crossed with the Duchenne muscular dystrophy (DMD) model <italic>mdx</italic> mice, these mice show both histological and functional improvements of their dystrophic phenotypes. This was partly due to the effect of increased ECs leading to an increase in MuSCs (<xref ref-type="bibr" rid="bib90">Verma et al., 2010</xref>; <xref ref-type="bibr" rid="bib92">Verma et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Bosco et al., 2021</xref>). However, the effect of VEGFA on MuSC in vivo remained unknown. We found that MuSCs express low levels of canonical EC markers including VEGF receptors using single cell transcriptomics. Therefore, we examined the effects of VEGFA on MuSCs and show that it has a drastic effect on cell survival in the via its receptor FLT1 by signaling through AKT1.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>EC gene signal including <italic>Vegf receptors</italic> in MuSCs</title><p>EC signatures in MuSCs has been seen in several gene expression data sets (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–1D</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>; <xref ref-type="bibr" rid="bib26">Fukada et al., 2007</xref>; <xref ref-type="bibr" rid="bib12">Charville et al., 2015</xref>; <xref ref-type="bibr" rid="bib76">Ryall et al., 2015</xref>; <xref ref-type="bibr" rid="bib87">van Velthoven et al., 2017</xref>). However, with the lack of EC control, we questioned whether these were true expression or artifact. To isolate EC and MuSC populations, we first crossed the <italic>Flk1<sup>+/GF</sup></italic><sup>P</sup> mice to label the ECs of the vasculature (<xref ref-type="bibr" rid="bib24">Ema et al., 2006</xref>) and the <italic>Pax7<sup>+/CreERT2</sup>:ROSA26<sup>+/Loxp-stop-Loxp-tdTomato</sup></italic> (<italic>Pax7<sup>+/CreERT2</sup>:R26R<sup>+/tdT</sup></italic>) mice to mark the MuSC lineage (<xref ref-type="bibr" rid="bib66">Murphy et al., 2011</xref>; <xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>). We performed bulk RNA sequencing (RNA-seq) on FACS sorted ECs and MuSCs as well as freshly isolated single muscle fibers (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E–G</xref>). We found that single muscle fibers routinely have ECs fragments attached to the fiber (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>) and so we removed such fibers based on <italic>Flk1<sup>GFP</sup></italic> expression from the samples collected for sequencing. We surveyed for canonical genes for each cell type (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) and found minimal but reliable expression of canonical ECs genes such as <italic>Pecam1</italic>, <italic>Cdh5</italic>, <italic>Kdr</italic>, and <italic>Flt1</italic> in MuSCs.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>EC gene signal including VEGF receptor genes in MuSCs.</title><p>(<bold>A</bold>) Experimental schema for bulk and scRNA-seq from the <italic>Pax7<sup>CreERT2</sup>:R26R<sup>tdT</sup>:Flk1<sup>GF</sup></italic><sup>P</sup> mice. Bulk RNA-seq performed on MuSCs, ECs and single muscle fibers (SMFs) from uninjured muscle. FACS sorted MuSCs and ECs from uninjured and regenerating TA muscle (3 days following CTX) were run separately on the 10 X single cell platform and aggregated. This panel created with <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender.com</ext-link>, and published using a BW26O8AXHL license with permission. (<bold>B</bold>) Bulk RNA-seq showing EC signature in MuSCs. Subset dividing genes that are commonly used to delineate cell identity for MuSCs, ECs and SMFs. Last column shows genes that define macrophages (Mφ), which should not be highly expressed in any on our cell types. Red dots indicate MuSCs, green dots indicate ECs and blue dots indicate SMFs. Data show mean ± SD (n=3). (<bold>C</bold>) UMAP from aggregated single cell RNA-seq shows expression of different phases of MuSCs (quiescent MuSCs, activated MuSCs and myoblasts), ECs (tip ECs and ECs) and from likely contaminant cells such as macrophages (Mφ) and smooth muscle cells (SMC). (<bold>D</bold>) UMAP from aggregated data visualized by sample day showing MuSCs segregated by the sample day but overlap in the EC population. Red dots indicate intact (day 0) and blue dots indicate 3 days following CTX. (<bold>E</bold>) Expression of quality control genes such as <italic>eGFP</italic>, <italic>tdTomato</italic>, <italic>CreERT2,</italic> and EC genes such as <italic>Cdh5</italic>, <italic>Kdr,</italic> and <italic>Flt1</italic>. (<bold>F</bold>) Genome browser tracks of whole muscle and TU-tagged MuSC nascent RNA (GSE97399, <xref ref-type="bibr" rid="bib87">van Velthoven et al., 2017</xref>). <italic>Kdr</italic> and <italic>Pecam1</italic> expression can be found in the MuSC fraction. As control, <italic>Myh1</italic> is highly expressed in the whole muscle preparation but largely absent in the MuSC fraction. <italic>Sdc4</italic> and <italic>Calcr</italic> are highly expressed in MuSC and less so in the whole muscle fraction. (<bold>G</bold>) qPCR for <italic>Kdr, Flt1, Nrp1</italic> and <italic>Nrp2</italic> in EC lines (bEnd.3 and C166), muscle cell line (C2C12) and MuSC-derived myoblasts in growth and differentiation medium (DM) shows low level expression of VEGFRs and VEGF co-receptors. Data show mean ± SD (n=3). (<bold>H</bold>) RNAScope of <italic>Flt1</italic> on freshly isolated single muscle fibers from <italic>Pax7<sup>tdT</sup></italic> mice shows <italic>Flt1</italic> expression (green) and tdTomato (red) in MuSCs. Nuclei were counterstained with DAPI (blue). Scale bar indicates 5 µm. (<bold>I</bold>) Immunostaining for PECAM1, VE-cadherin (VE-Cad), VEGFA co-receptors (NRP1 and NRP2) and VEGFA receptors (FLT1 and FLK1) in bEnd.3 EC cell line and MuSC-derived myoblasts (MB). Nuclei were counterstained with DAPI (blue). Scale bar indicates 20 µm.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Measurement of EC gene signal including VEGF receptor genes in MuSCs.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig1-v2.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 1 was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0</ext-link>. Further reproductions must adhere to the terms of this license</license-p></license></permissions></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>EC gene signal in MuSCs.</title><p>(<bold>A, B, C and D</bold>) MuSC and EC genes expressed in MuSC from various published repositories show a discrepancy in expression of EC-related genes [GSE3483 (n=3), <xref ref-type="bibr" rid="bib26">Fukada et al., 2007</xref>; GSE64379 (n=2), <xref ref-type="bibr" rid="bib76">Ryall et al., 2015</xref>; GSE113631 (n=2), <xref ref-type="bibr" rid="bib101">Yue et al., 2020</xref>; GSE97399 (n=3), <xref ref-type="bibr" rid="bib87">van Velthoven et al., 2017</xref>]. Data show mean ± SD. (<bold>E</bold>) Example of FACS isolation of Flk1<sup>GFP</sup>(<italic>+</italic>) ECs and Pax7<sup>tdT</sup>(+) MuSCs from <italic>Pax7<sup>+/CreERT2</sup>:R26R<sup>+/tdT</sup>:Flk1<sup>+/GF</sup></italic><sup>P</sup> mice. (<bold>F</bold>) Green (Green FL) and red (Red FL) fluorescence microscopic images of freshly isolated Flk1<sup>GFP</sup>(<italic>+</italic>) ECs and Pax7<sup>tdT</sup>(<italic>+</italic>) MuSCs from <italic>Pax7<sup>+/CreERT2</sup>:R26R<sup>+/tdT</sup>:Flk1<sup>+/GF</sup></italic><sup>P</sup> mice. Nuclei were counterstained with DAPI (blue). Scale bar indicates 100 µm. (<bold>G</bold>) EC fragment contamination with single muscle fiber (SMF) preparation. Flk1<sup>GFP</sup>(<italic>+</italic>)ECs (arrow, green) from the <italic>Pax7<sup>+/CreERT2</sup>:R26R<sup>+/tdT</sup>:Flk1<sup>+/GF</sup></italic><sup>P</sup> mice can be found enwrapping the muscle fibers when single muscle fibers (SMFs) were isolated, and that may result in EC gene expression in muscle fiber preparation. Arrowheads indicate Pax7<sup>tdT</sup>(+) MuSCs (red). Nuclei were counterstained with DAPI (blue). Scale bar indicates 10 µm. (<bold>H</bold>) FACS shows clear delineation between the SSC and FSC in quiescent vs. activated MuSCs isolated from day 3-injured muscle of <italic>Pax7<sup>+/CreERT2</sup>:R26R<sup>+/tdT</sup>:Flk1<sup>+/GF</sup></italic><sup>P</sup> mouse. (<bold>I</bold>) Quantification of quiescent MuSCs (QSCs) vs. activated MuSCs (ASCs) based only on the FSC and SSC from basal and regenerating muscle from <italic>Pax7<sup>+/CreERT2</sup>:R26R<sup>+/tdT</sup>:Flk1<sup>+/GF</sup></italic><sup>P</sup> mice. Data show mean ± SD (n=3). (<bold>J</bold>) Genes used to define different cell identities in the scRNA-seq. Of note, quiescent MuSCs were supported by high expression of <italic>Hes1</italic> in myogenic cells, activated MuSCs were defined as myogenic cells with high expression of <italic>Ccnd1</italic> and myoblasts were defined as myogenic cells expressing <italic>Myogenin</italic> (<italic>Myog</italic>). Activated ECs were defined as the population having higher <italic>Ccnd1</italic> expression. (<bold>K</bold>) Background subtraction using SoupX maintains EC identity in the <italic>tdTomato</italic>(<italic>+</italic>) and <italic>CreERT2</italic>(<italic>+</italic>) myogenic cell clusters as evident by preserved expression of EC genes (<italic>eGFP</italic> and <italic>Cdh5</italic>). (<bold>L</bold>) <italic>Calcr</italic>(<italic>+</italic>), <italic>Myog</italic>(<italic>+</italic>) and <italic>Cdk1</italic>(+) myogenic cell cluster from aggregated scRNA-seq collection (GSE143437, <xref ref-type="bibr" rid="bib19">De Micheli et al., 2020</xref>) shows <italic>Flt1</italic> is expressed diffusely throughout the whole myogenic population.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Measurement of EC gene signal in MuSCs.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig1-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig1-figsupp1-v2.tif"/></fig></fig-group><p>It is possible that these EC signatures detected in MuSCs were due to small amounts of contaminating ECs with very high expression of the canonical EC genes skewing the average expression in MuSC RNA samples. To rule out this possibility, we performed single-cell RNA-seq (scRNA-seq) on MuSCs and ECs isolated from mouse hind limb muscle from both basal condition and 3 days post intramuscular cardiotoxin (CTX) injury to look at both quiescent and activated MuSCs from the reporter mice specified above (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We could reliably delineate injured and activated MuSCs via side and forward scatter (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H and I</xref>). We FACS isolated cells from both days separately and spiked in 20% of the ECs into the MuSCs from their respective time points, and performed scRNA-seq for each time point (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We performed sequencing with ~300 K read/cell compared with the commonly used sequencing with 60 K reads/cell, in order to maximize the possibility of detecting low-abundance transcripts (<xref ref-type="bibr" rid="bib102">Zhang et al., 2020</xref>). In the aggregated dataset, the MuSCs showed low overlap between D0 and D3 owing to the different stages of the myogenic differentiation cycle, while the ECs clusters showed near perfect overlap (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>). While drastic morphological changes in ECs have been shown during muscle regeneration (<xref ref-type="bibr" rid="bib34">Hardy et al., 2016</xref>), transcriptomic changes are much more tapered, especially compared with MuSCs (<xref ref-type="bibr" rid="bib46">Latroche et al., 2017</xref>). We were able to deconvolve the quiescent MuSCs from the activated and differentiating MuSCs, ECs, and other cell types from gene signatures. (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1J</xref>). Importantly, data from scRNA-seq were able to recapitulate the minimal expression of canonical EC genes in the MuSC clusters such as <italic>Cdh5</italic> (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) as seen in our Bulk RNA-seq results (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). These included the Vegf receptors <italic>Flk1</italic> (<italic>Kdr</italic>) and <italic>Flt1</italic> (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p><p>As a quality control measure, we introduced an artificial chromosome into our reference genome with sequences for the three transgene genes; <italic>eGFP</italic> from <italic>Flk1<sup>+/GF</sup></italic><sup>P</sup>, <italic>tdTomato</italic> and <italic>CreERT2</italic> from <italic>Pax7<sup>+/CreERT2</sup>:R26R<sup>+/tdT</sup></italic> and used this genome to map our single cell RNA-seq data (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K</xref>). Surprisingly, we also found <italic>eGFP</italic> in the MuSCs and <italic>tdTomato</italic> in EC fraction, while the <italic>CreERT2</italic> expression remained mainly restricted to the MuSCs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K</xref>). FACS analysis and FACS-sorted cells confirmed that GFP(+) and tdTomato(+) cells are exclusively restricted as ECs and MuSCs, respectively (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E and F</xref>). Therefore, we hypothesized that this was due to the ambient-free mRNA from the digested cells that is intrinsic to any droplet based single-cell sequencing platform. By using SoupX (<xref ref-type="bibr" rid="bib100">Young and Behjati, 2020</xref>), we performed careful background subtraction using genes expressed exclusively in myofibers as our negative control and genes validated by in situ hybridization as a positive control (<xref ref-type="bibr" rid="bib39">Kann and Krauss, 2019</xref>). We observed decreased but sustained <italic>eGFP</italic> expression in the MuSC fraction and <italic>tdTomato</italic> expression in the EC fraction after SoupX subtraction (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K</xref>). In addition, the EC signatures such as <italic>Cdh5</italic> expression in the MuSC fraction was also sustained. These results conclude that MuSCs contain mRNAs from canonical ECs genes. We showed that the canonical EC genes, such as <italic>Cdh5</italic>, <italic>Flt1</italic> and <italic>Flk1</italic> were broadly expressed in the myogenic cells in our dataset (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p><p>Since detection of rare subpopulation in single cell dataset is a factor of cell numbers, we re-analyzed previously published dataset with 2,232 myogenic cells across different states (<xref ref-type="bibr" rid="bib83">Torre et al., 2018</xref>; <xref ref-type="bibr" rid="bib19">De Micheli et al., 2020</xref>). We were able to classify cell as quiescent, proliferative vs. differentiating states based on the expression of <italic>Calcr</italic>, <italic>Cdk1,</italic> and <italic>Myog</italic>, respectively (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1L</xref>). We noticed that EC prototypic markers such as <italic>Flt1</italic> are broadly expressed with small amounts in MuSCs. Complementary data from different laboratories showed the clear expression of EC prototypic markers such as <italic>Cdh5</italic>, <italic>Flt1,</italic> and <italic>Kdr</italic>, using microarrays and Bulk-RNA-seq (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A and B</xref>; <xref ref-type="bibr" rid="bib26">Fukada et al., 2007</xref>; <xref ref-type="bibr" rid="bib76">Ryall et al., 2015</xref>). RNA-seq data from fixed quiescent, early activated and late activated MuSCs show that <italic>Flt1</italic> may be transiently upregulated during the early activation process (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>; <xref ref-type="bibr" rid="bib101">Yue et al., 2020</xref>). To confirm whether the EC gene mRNAs were transcribed from MuSCs, we utilized previously published MuSC nascent RNA transcriptome from TU-tagged samples (<xref ref-type="bibr" rid="bib27">Gay et al., 2013</xref>; <xref ref-type="bibr" rid="bib87">van Velthoven et al., 2017</xref>). As expected, <italic>Myh1</italic> was represented in the whole muscle but was absent in the TU-tagged MuSCs (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), indicating that the nascent MuSCs were devoid of cellular contamination from other cells in the muscle. Inversely, the nascent MuSC transcript was over-represented for MuSC related genes such as <italic>Calcr</italic> and <italic>Sdc4</italic>. Interestingly, we were able to detect EC genes such as <italic>Kdr</italic> and <italic>Pecam1</italic> in the TU-tagged MuSC samples indicating that they were actively transcribed by MuSCs (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>).</p><p>We also verified the expression of <italic>Vegfr</italic> genes (<italic>Kdr</italic>, <italic>Flt1</italic>, <italic>Nrp1,</italic> and <italic>Nrp2</italic>) in MuSCs using RT-qPCR (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). In addition, we verified the expression of <italic>Flt1</italic> by performing in situ hybridization using RNAScope on MuSC on whole muscle fiber, which we currently believe to be the gold standard for expression studies (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). Finally, in MuSC-derived myoblasts, NRP1and NRP2 expression was detectable with comparable intensity compared with EC cell line, while FLT1 expression was detectable with lower intensity compared with EC cell line (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). By contrast, PECAM1, VE-Cadherin and FLK1 expression, which was clearly detected in EC cell line, was undetectable level in myoblasts. Taken together, these data indicate that there are both transcripts of these EC canonical genes and EC canonical proteins in MuSCs.</p></sec><sec id="s2-2"><title>VEGFA induces proliferation and cell survival but not differentiation in myoblasts</title><p>Since VEGFRs were expressed in MuSCs in small amounts and their ligand, VEGFA, was highly expressed in MuSCs (<xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>), we wanted to investigate whether there were any biological effects to induction by VEGFA. We found that treatment with VEGFA could increase proliferation of MuSC-derived myoblasts at low dose but inhibit proliferation at high dose of VEGFA, a phenomenon that has been previously described in ECs (<xref ref-type="bibr" rid="bib67">Noren et al., 2016</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). We saw no effect on differentiation by VEGFA as evaluated by myosin heavy chain (MyHC) staining, fusion index and RT-qPCR (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B–D</xref>). By contrast, crystal violet staining showed that VEGFA could significantly increase survival as judged by number of myoblasts following UV-mediated apoptotic cell death induction (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E and F</xref>). To investigate apoptosis in detail, we optimized Annexin V assay following thapsigargin-mediated endoplasmic reticulum (ER)-stress (<xref ref-type="bibr" rid="bib35">Hirai et al., 2010</xref>) so that we could study deviation at ~ED50 while still performing experiments to remove the confounding variable to proliferation from the experimental setup (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G and H</xref>). We had previously shown that MuSCs are the predominant cells that secrete VEGFA in skeletal muscle (<xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>) and while adding exogenous VEGFA did not improve cell survival, blocking VEGFA via a soluble form of FLT1-FC increased the number of apoptotic and necrotic myoblasts in vitro (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>VEGFA-FLT1-AKT1 axis controls apoptosis in MuSC in vitro.</title><p>(<bold>A</bold>) Experimental scheme for assessing apoptosis following thapsigargin induction in myoblast culture. (<bold>B</bold>) Decreased cell survival in myoblast in vitro as VEGFA is blocked using 100 ng/ml FLT1-FC (a VEFGA trap) following thapsigargin induction. This phenotype is partially rescued with exogenous VEGFA (50 ng/ml). Data show mean ± SD (n=3). (<bold>C</bold>) Graphical representation of the various tools used to interrogate the VEGFA pathway in this figure. This panel created with <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender.com</ext-link>, and published using a TQ26O8B2M7 license with permission. (<bold>D</bold>) Following thapsigargin induction, apoptotic and necrotic cells are increased with inhibition of FLT1 via FLT1-FC or anti-FLT1 antibody (anti-FLT1 mAb) but not FLK1 (SU5402 and ZM306416) or NRP1-FLK1 inhibition (EG00229) following exogenous VEGFA (50 ng/ml). Data show mean ± SD (n=3). (<bold>E</bold>) 4-OHT induced deletion of <italic>Flt1</italic> in <italic>Pax7<sup>+/CreER</sup>:Flt1<sup>Loxp/Loxp</sup></italic> myoblasts is sufficient to reduce cell survival in myoblast without induction of apoptosis. Data show mean ± SD (n=3). (<bold>F</bold>) Cell survival is decreased in vitro in myoblast with thapsigargin induction following 4-OHT mediated deletion of <italic>Flt1</italic> in <italic>Pax7<sup>+/CreER</sup>:Flt1<sup>Loxp/Loxp</sup></italic> myoblast that is not rescued by exogenous VEGFA. Blue indicates MuSC<italic>-Flt1<sup>+/+</sup></italic>, red indicates MuSC<italic>-Flt1<sup>+/+</sup></italic> with 50 ng/ml VEGFA, green indicates MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> and purple indicates MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> with 50 ng/ml VEGFA. Data show mean ± SD (n=3). (<bold>G</bold>) Representative images of pAKT1 (red) in myoblast stained by MyoD (green) in MuSC<italic>-Flt1<sup>+/+</sup></italic> and MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> myoblasts induced with exogenous VEGFA. Nuclei were counterstained with DAPI (blue). Scale bar indicates 50 µm. (<bold>H</bold>) Quantification of pAKT1 in myoblasts stained by MyoD in MuSC<italic>-Flt1<sup>+/+</sup></italic> and MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> myoblast induced w/wo exogenous VEGFA. VEGFA induction increases pAKT1 in MuSC<italic>-Flt1<sup>+/+</sup></italic> myoblasts but this response is lost in MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> myoblasts. Data show mean ± SD (n=3). (<bold>I</bold>) Annexin V quantification of myoblasts transfected with myr-AKT1 and E4ORF1 to activate AKT1 showed increased cell survival of myoblasts following thapsigargin induction. Data show mean ± SD (n=3). (<bold>J</bold>) Representative model for VEGFA-FLT1-AKT1 axis-mediated MuSC survival. This panel created with <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender.com</ext-link>, and published using a TQ26O8B2M7 license with permission.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Measurement of VEGFA-FLT1-AKT1 axis for apoptosis in MuSC in vitro.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig2-v2.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 2 was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0</ext-link>. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>VEGFA-FLT1-AKT1 axis for cell survival in MuSC in vitro.</title><p>(<bold>A</bold>) MuSC-derived myoblast proliferation as assessed by % EdU following 6 hr of induction with exogenous VEGFA is increased at 20 ng/ml but decreased at 100 ng/ml. Data show mean ± SD (n=3). (<bold>B</bold>) Representative images of myoblast differentiation for 1 day stained with MyHC following bFGF or VEGFA treatment. Nuclei were counterstained with DAPI (blue). Scale bar indicates 100 µm. (<bold>C</bold>) Quantification of experiment shown in panel A showing that fusion index (equal or greater than 2 nuclei per cell) following 3 days in the differentiation medium is reduced by exogenous 20 ng/ml bFGF but unchanged with 20 ng/ml VEGFA. Data show mean ± SD (n=4). (<bold>D</bold>) <italic>Myh3</italic> expression normalized by <italic>Htatsf1</italic> in myoblasts was unchanged with exogenous VEGFA following 3 days in the differentiation medium. Data show mean ± SD (n=3). (<bold>E</bold>) Representative image of myoblast stained with crystal violet treated with VEGFA following induction of apoptosis via UV light. Scale bar indicates 200 µm. (<bold>F</bold>) Quantification of experiment shown in panel E shows improved cell survival of myoblasts with 20 ng/ml of VEGFA following induction of apoptosis via UV light. (<bold>G</bold>) Example of Annexin V/PI staining used for quantification of apoptosis by FACS shows the transition from live cells to apoptotic cells and necrotic cells following thapsigargin induction. (<bold>H</bold>) Time course of thapsigargin-induced cell apoptosis shows that cell survival is reduced to ~50% at 24 hr following thapsigargin induction. (<bold>I</bold>) RT-qPCR shows deletion of the <italic>Flt1</italic> exon 3 in MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> myoblasts while exons 1 and 2 are retained in MuSC<italic>-Flt1<sup>+/+</sup></italic> myoblasts. Data show mean ± SD (n=3). (<bold>J</bold>) Anti-FLT1 antibody staining shows downregulation of FLT1 in MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> myoblasts while FLT1 is detected in MuSC<italic>-Flt1<sup>+/+</sup></italic> myoblasts. Nuclei were counterstained with DAPI (blue). Scale bar indicates 50 µm. (<bold>K</bold>) Myoblast proliferation as assessed by % EdU in MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> cells was not significantly altered compared with MuSC<italic>-Flt1<sup>+/+</sup></italic> cells. Data show mean ± SD (n=3). (<bold>L</bold>) Myogenic differentiation as assessed by MyHC staining in MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> myoblasts was not significantly altered compared with MuSC<italic>-Flt1<sup>+/+</sup></italic> myoblasts following 3 days in the differentiation medium. Data show mean ± SD (n=3). (<bold>M</bold>) Representative images of myoblast cultures following EdU exposure in growth medium stained for EdU (green) and MyHC (red). Nuclei were counterstained with DAPI (blue). Scale bar indicates 100 µm. (<bold>N</bold>) Western blotting for pAKT proteins (62 kDa) in MuSC<italic>-Flt1<sup>+/+</sup></italic> and MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> myoblasts with or without VEGFA treatment. GAPDH (36 kDa) was used as an internal control for loading. (<bold>O</bold>) Western blotting showed reduced amounts of pAKT1 in MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> myoblasts with or without VEGFA treatment compared to MuSC<italic>-Flt1<sup>+/+</sup></italic> myoblasts. Data show mean ± SD (n=3).</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Measurement of VEGFA-FLT1-AKT1 axis for cell survival in MuSC in vitro.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Uncropped blotting image of <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1N</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-73592-fig2-figsupp1-data2-v2.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>VEGFA-facilitated cell survival in MuSC-derived myoblasts is mediated through FLT1</title><p>To characterize the VEGF receptor responsible for the anti-apoptotic effect of VEGFA on MuSC-derived myoblasts, we used pharmacological inhibitors of the VEGF receptors (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>). We used blocking antibody for the VEGF receptors FLT1 (anti-FLT1 antibody), small molecule inhibitors for FLK1 (SU4502 and ZM306416) and the FLK1 co-receptor NRP1 (EG00229) following thapsigargin induction (<xref ref-type="fig" rid="fig2">Figure 2A and D</xref>). Surprisingly, inhibiting FLK1, the major signaling RTK for VEGFA, had no effect on myoblasts survival following thapsigargin induction (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). By contrast, blocking FLT1 via blocking antibody greatly decreased the survival of myoblasts following thapsigargin induction (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). To confirm this interesting result using genetic tools, we obtained myoblasts with <italic>Pax7-CreER</italic>-inducible deletion of <italic>Flt1</italic> mice (<italic>Pax7<sup>+/CreER</sup>:Flt1<sup>Loxp/Loxp</sup></italic> or MuSC-<italic>Flt1<sup>Δ/Δ</sup></italic>) and the control mice (<italic>Pax7<sup>+/+</sup>:Flt1<sup>Loxp/Loxp</sup></italic>). In vitro 4-OHT-mediated genetic deletion of <italic>Flt1</italic> (MuSC-<italic>Flt1<sup>Δ/Δ</sup></italic>) resulted in down-regulation of <italic>Flt1</italic> RNA and FLT1 protein expression (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1I and J</xref>), and increased spontaneous apoptotic cell death even without induction of apoptosis (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). By contrast, <italic>Flt1</italic> deletion did not affect cell proliferation assessed by EdU staining or myogenic differentiation assessed by MyHC staining (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1K–M</xref>). When thapsigargin-induced apoptosis was induced, the MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> myoblasts had increased apoptosis that was not responsive to exogenous VEGFA (<xref ref-type="fig" rid="fig2">Figure 2F</xref>).</p></sec><sec id="s2-4"><title>AKT1 signaling is involved in apoptosis of muscle stem cells</title><p>VEGFA signaling is mediated through Extracellular signal-Regulated Kinase (ERK), p38 Mitogen-Activated Protein Kinase (MAPK), and Protein kinase B (AKT1). In ECs, VEGFA is known to protect cells from apoptosis via AKT1 (<xref ref-type="bibr" rid="bib21">Domigan et al., 2015</xref>; <xref ref-type="bibr" rid="bib48">Lee et al., 2007</xref>). However, it is not known whether VEGFA can similarly activate AKT1 in MuSC-derived myoblasts. While the role of AKT1 has been explored in proliferation and differentiation in myoblasts, its role in apoptosis has not been well characterized (<xref ref-type="bibr" rid="bib53">Loiben et al., 2017</xref>). We assessed for AKT1 activation via phosphorylated AKT1 (pAKT1) in MuSC-derived myoblasts. We found that exogenous VEGFA could induce AKT1 phosphorylation (pAKT1) (<xref ref-type="fig" rid="fig2">Figure 2G and H</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1N and O</xref>). This response was blunted in MuSC-<italic>Flt1<sup>Δ/Δ</sup></italic> myoblasts and was no longer responsive to VEGFA (<xref ref-type="fig" rid="fig2">Figure 2G and H</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1N and O</xref>). Lastly, we wanted to confirm that AKT1 activation could improve myoblast survival. We infected lentiviral <italic>E4ORF1</italic> or <italic>MyrAKT1</italic> vectors in myoblasts, both of which gene products have been shown to specifically activate AKT1 without activating ERK or p38 (<xref ref-type="bibr" rid="bib42">Kobayashi et al., 2010</xref>). We found that overexpression of either of these genes improved cell survival compared with the control in vitro following induction of apoptosis via thapsigargin (<xref ref-type="fig" rid="fig2">Figure 2I</xref>). These data establish FLT1-AKT1 as the cascade linking VEGFA to apoptosis in MuSC-derived myoblasts during muscle regeneration (<xref ref-type="fig" rid="fig2">Figure 2J</xref>).</p></sec><sec id="s2-5"><title>VEGFA-FLT1 pathway protects MuSCs from apoptosis in vivo</title><p>Endogenous and exogenous VEGFA have been shown to regulate cell survival and protect ECs from apoptosis (<xref ref-type="bibr" rid="bib28">Gerber et al., 1998</xref>; <xref ref-type="bibr" rid="bib48">Lee et al., 2007</xref>). To assess whether additional VEGFA had an effect on MuSC behaviors in vivo, we used mice carrying the <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> allele for injury-mediated TA muscle regeneration following BaCl<sub>2</sub> injection (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>; <xref ref-type="bibr" rid="bib61">Miquerol et al., 1999</xref>). MuSC-derived myoblasts from <italic>Pax7<sup>+/tdT</sup>:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice showed around 2.8-fold increased expression of <italic>Vegfa</italic> but not the <italic>Vegfr</italic> genes compared with myoblasts from wild-type mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). Interestingly, while treatment with VEGFA alone had no effect on apoptosis in vitro, the MuSCs from <italic>Pax7<sup>+/tdT</sup>:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice showed decreased cell death in regenerating muscle by 1 day following BaCl<sub>2</sub> injection (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Consequently, single muscle fibers from <italic>Pax7<sup>+/tdT</sup>:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice showed increased number of MuSCs, compared with those from <italic>Pax7<sup>+/tdT</sup>:Vegfa<sup>+/+</sup></italic> mice by 28 days following BaCl<sub>2</sub> injection (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). In addition, muscle regeneration was promoted in <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice in the early (14 days) and late (28 days) muscle repair processes as judged by fiber diameter and increase in eMHC(+) regenerating muscle fibers (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B–F</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>MuSC-derived <italic>VEGFA</italic> and <italic>Flt1</italic> requires proper skeletal muscle regeneration.</title><p>(<bold>A</bold>) Experimental schema detailing the experiments performed in this figure. The <italic>Pax7<sup>+/CreER</sup>:R26R<sup>tdT</sup>:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> (<italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup>) <italic>Pax7<sup>+/CreER</sup>:R26R<sup>tdT</sup>:Vegfa<sup>Loxp/Loxp</sup> for</italic> MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> and <italic>Pax7<sup>tdT</sup>:Flt1<sup>Loxp/Loxp</sup></italic> for MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> lines were pulsed with tamoxifen (TMX) prior to BaCl<sub>2</sub>-induced muscle injury followed by investigations. (<bold>B</bold>) Representative H&amp;E-stained images for intact and on 14-day post injury TA muscle from MuSC<italic>-Vegfa<sup>+/</sup></italic><sup>Hyper</sup><italic>,</italic> MuSC<italic>-Flt1<sup>Δ/Δ</sup> and</italic> MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> mice and their representative controls. Scale bar indicates 100 µm. (<bold>C</bold>) Annexin V staining show less necrotic cells in MuSC from <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice compared with the control one day following injury. Data show mean ± SD (n=3). (<bold>D</bold>) Quantification of MuSCs from single muscle fibers show increased Pax7 immunofluorescence positive MuSCs in <italic>Vegfa<sup>+/Hyper</sup></italic> EDL muscle compared with the control mice at base line and 14 days post injury. Data show mean ± SD (n=4). (<bold>E</bold>) Fiber size distribution and (<bold>F</bold>) mean feret’s diameter of uninjured and regenerating muscle 14 days post injury from <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> and control mice show no difference at baseline but an increase in fiber diameter following injury. Data show mean ± SD (n=3). (<bold>G</bold>) Annexin V staining show increased dead cells in MuSCs from MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> mice one day following BaCl<sub>2</sub> compared with the control MuSC<italic>-Vegfa<sup>+/+</sup></italic> mice. Data show mean ± SD (n=4). (<bold>H</bold>) Quantification of MuSCs from single muscle fiber at base line and 14 days post injury shows no difference at baseline and reduced MuSC numbers at 14 days. Data show mean ± SD (n=4). (<bold>I</bold>) Fiber size distribution and (<bold>J</bold>) mean feret’s diameter of uninjured and regenerating muscle 14 days post injury from MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> and MuSC<italic>-Vegfa<sup>+/+</sup></italic> mice show no difference at baseline but a decrease in fiber diameter following injury. Data show mean ± SD (n=3 or 5). (<bold>K</bold>) Annexin V staining show increased apoptosis in MuSCs from MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mice one day following injury compared with the control MuSC<italic>-Flt1<sup>+/+</sup></italic> mice. Data show mean ± SD (n=4). (<bold>L</bold>) Quantification of MuSCs from single muscle fiber show decreased MuSCs in MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> EDL muscle at base line and 14 days post injury compared with the control MuSC<italic>-Flt1<sup>+/+</sup></italic> mice. Data show mean ± SD (n=4). (<bold>M</bold>) Fiber size distribution and (<bold>N</bold>) mean feret’s diameter of uninjured and regenerating muscle from MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> and compared with the control MuSC<italic>-Flt1<sup>+/+</sup></italic> mice show no difference at baseline but a decrease in fiber diameter following injury. Data show mean ± SD (n=3).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Measurement of MuSC-derived VEGFA and Flt1 for proper skeletal muscle regeneration.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>MuSC-derived VEGFA and Flt1 for skeletal muscle regeneration.</title><p>(<bold>A</bold>) <italic>Vegfa</italic> is increased in <italic>Vegfa<sup>+/</sup></italic><sup>Hype<italic>r</italic></sup> mouse muscle but does not lead to an increase in <italic>Flk1,</italic> soluble <italic>Flt1</italic> (<italic>sFlt1</italic>) or membrane-bound <italic>Flt1</italic> (<italic>mFlt1</italic>). Data show mean ± SD (n=3). (<bold>B</bold>) Representative H&amp;E images from <italic>Vegfa<sup>+/+</sup></italic> and <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mouse TA muscle in 28 days post-injury. Scale bar indicates 50 µm. (<bold>C</bold>) Fiber size distribution and (<bold>D</bold>) mean feret’s diameter of uninjured muscle from <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice show an increase in fiber diameter compared with the control following injury. Data show mean ± SD (n=4). (<bold>E</bold>) eMHC(+) fibers (green) in the TA muscle sections of MuSC<italic>-Vegfa <sup>Δ/Δ</sup></italic>, MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> and <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice were compared with the control MuSC<italic>-Vegfa<sup>+/+</sup></italic>, MuSC<italic>-Flt1<sup>+/+</sup></italic> and <italic>Vegfa<sup>+/+</sup></italic> mice day 4 following BaCl<sub>2</sub> injection. Red and blue staining show laminin staining and DAPI. Scale bar indicates 20 µm. (<bold>F</bold>) TA muscle sections of MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic>, MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> and <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice compared with the control MuSC<italic>-Vegfa<sup>+/+</sup></italic>, MuSC<italic>-Flt1<sup>+/+</sup></italic> and <italic>Vegfa<sup>+/+</sup></italic> mice show decreased (MuSC<italic>-Vegfa <sup>Δ/Δ</sup></italic> and MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic>) and increased (<italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup>) eMHC(+) fibers day 4 following BaCl<sub>2</sub> injection. Data show mean ± SD (n=3).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Mesurement of MuSC-derived VEGFA and Flt1 for skeletal muscle regeneration.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>MuSC-derived VEGFA and Flt1 regulating skeletal muscle regeneration.</title><p>(<bold>A</bold>) Anti-VEGFA antibody staining shows downregulation of VEGFA protein (green) in MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> myoblasts while VEGFA is detected in MuSC<italic>-Vegfa<sup>+/+</sup></italic> myoblasts. Pax7<sup>tdT</sup>(+) cells (red) was clearly detected only in MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> myoblasts but not in MuSC<italic>-Vegfa<sup>+/+</sup></italic> myoblasts. Nuclei were counterstained with DAPI (blue). Scale bar indicates 25 µm. (<bold>B</bold>) Representative H&amp;E and Oil Red O (showing fat infiltration as red color) images from regenerating TA muscle of MuSC<italic>-Vegfa<sup>+/+</sup></italic> and MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> mice in 28 days post-injury. Scale bar indicates 100 µm. (<bold>C</bold>) Fiber size distribution and (<bold>D</bold>) average fiber diameters are decreased in MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> mouse TA muscle compared with the control from <italic>Vegfa<sup>+/+</sup></italic> mouse TA muscle. Data show mean ± SD (n=4). (<bold>E</bold>) Average Oil Red O(+) fat infiltration from regenerating TA muscle of MuSC<italic>-Vegfa<sup>+/+</sup></italic> and MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> mice in 28 days post-injury. Data show mean ± SD (n=4). (<bold>F</bold>) Representative H&amp;E images from MuSC<italic>-Flt1<sup>+/+</sup></italic> and MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mouse TA in 7 and 14 days post-injury. Scale bar indicates 100 µm. (<bold>G</bold>) Fiber size distribution and (<bold>H</bold>) mean feret’s diameter are decreased 7 days post-injury in MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mouse TA muscle compared with the control from MuSC<italic>-Flt1<sup>+/+</sup></italic> mouse TA muscle. Data show mean ± SD (n=3). (<bold>I</bold>) Fiber size distribution and (<bold>J</bold>) average fiber diameter are decreased 14 days post-injury in MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mouse TA muscle compared with the control from MuSC<italic>-Flt1<sup>+/+</sup></italic> mouse TA muscle. Data show mean ± SD (n=4 or 5).</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Measurement of MuSC-derived VEGFA and Flt1 during skeletal muscle regeneration.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig3-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig3-figsupp2-v2.tif"/></fig></fig-group><p>We then performed the reciprocal experiment to investigate the consequence of <italic>Vegfa</italic> loss in MuSCs in vivo, and utilized MuSC-specific <italic>Vegfa</italic> knockout mice (<italic>Pax7<sup>+/CreER</sup>:Vegfa<sup>Loxp/Loxp</sup></italic>). We have previously shown that vasculature in the MuSC-<italic>Vegfa<sup>Δ/Δ</sup></italic> mouse muscle is perturbed and the proximity between the MuSC and EC is increased (<xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>). However, the functional consequences of this remained unknown. We confirmed that clear downregulation of VEGFA protein in MuSC-derived myoblasts isolated from MuSC-<italic>Vegfa<sup>Δ/Δ</sup></italic> mice (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). We noticed that deletion of <italic>Vegfa</italic> in MuSCs in the MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> mouse muscle led to an increase in the proportion of dead MuSCs following BaCl<sub>2</sub> injection (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). Consequently, the number of MuSCs in the MuSC-<italic>Vegfa<sup>Δ/Δ</sup></italic> muscle were significantly reduced following recovery after injury without difference in the MuSC numbers in MuSC-<italic>Vegfa<sup>Δ/Δ</sup></italic> muscle at homeostasis (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). In addition, the muscle had a regenerative defect as indicated by the shift in fiber size distribution, decrease in the size of regenerating eMHC(+) fiber and increased adipose following muscle injury (<xref ref-type="fig" rid="fig3">Figure 3B, I and J</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B–E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and F</xref>). While a limitation of this experiment is that the MuSC fusion into the fiber also deletes <italic>Vegfa</italic> from the fiber themselves, muscle-fiber-specific deletion of <italic>Vegfa</italic> has not shown an effect on fiber size (<xref ref-type="bibr" rid="bib18">Delavar et al., 2014</xref>). These data indicate that cell intrinsic VEGFA improves cell survival of MuSCs and that loss of MuSC-derived VEGFA results in reduced muscle regeneration.</p><p>Since FLT1 but not FLK1 was detected in MuSCs and MuSC-derived myoblasts, we asked whether the <italic>Flt1</italic> had an effect on MuSC survival in vivo, we evaluated cell death in MuSCs from MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mouse muscle. We induced muscle regeneration using BaCl<sub>2</sub> for 1 day and assessed for cell death in MuSCs. As seen in vitro, we found that loss of <italic>Flt1</italic> in MuSCs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1I and J</xref>) resulted in increased cell death during early regeneration (<xref ref-type="fig" rid="fig3">Figure 3K</xref>). Consequently, single muscle fibers from MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mice showed a decreased number of MuSCs, compared with those from MuSC<italic>-Flt1<sup>+/+</sup></italic> mice by 28 days following BaCl<sub>2</sub> injection (<xref ref-type="fig" rid="fig3">Figure 3L</xref>). We also examined the long-term in vivo consequence of deleting <italic>Flt1</italic> from MuSC. There was no significant muscle phenotype in MuSC-<italic>Flt1<sup>Δ/Δ</sup></italic> muscle at homeostasis (<xref ref-type="fig" rid="fig3">Figure 3B, M and N</xref>). However, following injury, the MuSC-<italic>Flt1<sup>Δ/Δ</sup></italic> muscle had a modest regenerative defect as indicated by the shift in fiber size distribution following muscle injury and decrease in size of eMHC(+) regenerating fibers (<xref ref-type="fig" rid="fig3">Figure 3B, M and N</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2F–J</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and F</xref>).</p></sec><sec id="s2-6"><title>VEGFA-FLT1 pathway regulates muscle pathology in DMD model mice</title><p>While angiogenic defects have been reported in the <italic>mdx</italic> mice as well as in golden retrieval muscular dystrophy (GRMD; canine model of DMD) (<xref ref-type="bibr" rid="bib90">Verma et al., 2010</xref>; <xref ref-type="bibr" rid="bib45">Latroche et al., 2015</xref>; <xref ref-type="bibr" rid="bib92">Verma et al., 2019</xref>; <xref ref-type="bibr" rid="bib43">Kodippili et al., 2021</xref>; <xref ref-type="bibr" rid="bib72">Podkalicka et al., 2021</xref>), it is not clear whether VEGF family and its receptors are implicated in human dystrophinopathies. We probed the VEGF ligands and receptors in microarrays (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) from skeletal muscles and MuSCs from <italic>mdx</italic> mice (<xref ref-type="bibr" rid="bib85">Tseng et al., 2002</xref>; <xref ref-type="bibr" rid="bib70">Pallafacchina et al., 2010</xref>) and skeletal muscles from the GRMD (<xref ref-type="bibr" rid="bib94">Vieira et al., 2015</xref>). <italic>Vegfa</italic> was downregulated in both models (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). <italic>Flt1</italic> was also downregulated in GRMD but not <italic>mdx</italic> muscles. To examine whether VEGF signaling is altered in DMD patients, we performed gene expression analysis on previously available data from microarrays from patients with DMD (<xref ref-type="bibr" rid="bib13">Chen et al., 2000</xref>). We also aggregated and probed microarray data from muscle biopsies of patients with various neuromuscular diseases or of healthy individuals after exercise (<xref ref-type="bibr" rid="bib6">Bakay et al., 2006</xref>). In the microarray data, <italic>Vegfa</italic> expression was increased after an acute bout of exercise, and <italic>Vegfa</italic> expression was reduced in ALS muscle, BMD muscle, as well as both early and late phases of DMD muscle (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). These data indicate that <italic>Vegfa</italic> expression is decreased in dystrophinopathy, and thus increasing VEGFA may be a therapeutic target for DMD.</p><p>Therefore, we crossed the MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mice with the chronically regenerating DMD model mice (<italic>mdx</italic>) to generate <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mice, and analyzed long-term effects of <italic>Flt1</italic> deletion (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B and C</xref>). Importantly, we found a significant decrease in fiber diameter, increased fibrosis and CD31(+) capillary density (<xref ref-type="fig" rid="fig4">Figure 4B–D</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C and D</xref>) in TA muscle. This was accompanied by a physiological decrease in muscle perfusion as shown by laser Doppler flow at 12 months (<xref ref-type="fig" rid="fig4">Figure 4E</xref>) as well as a functional decline in muscle strength as judged by grip strength both acutely and chronically (<xref ref-type="fig" rid="fig4">Figure 4F</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>VEGFA-FLT1 pathway in MuSCs regulates muscle pathology in DMD model mice.</title><p>(<bold>A</bold>) Experimental schema detailing the experiments performed in this figure. The <italic>mdx:Pax7<sup>tdT</sup>:Flt1<sup>Loxp/Loxp</sup></italic> was pulsed with tamoxifen (TMX) to generate <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mice prior to investigation. <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mouse line was used without any induction. (<bold>B</bold>) Representative H&amp;E (scale bar, 100 µm), Sirius red staining (red; scale bar, 100 µm) and CD31(+) capillaries (green; scale bar, 25 µm) from <italic>mdx:</italic>MuSC<italic>-Flt1<sup>+/+</sup></italic> and <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mouse TA muscle at 3 months of age. (<bold>C</bold>) Smaller average fiber size in <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> compared with the control <italic>mdx:</italic>MuSC<italic>-Flt1<sup>+/+</sup></italic> mouse TA muscle. Data show mean ± SD (n=6). (<bold>D</bold>) Increased fibrotic area in <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> compared with the control <italic>mdx:</italic>MuSC<italic>-Flt1<sup>+/+</sup></italic> mouse TA muscle. Data show mean ± SD (n=4). (<bold>E</bold>) Decreased muscle perfusion in <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> compared with the control <italic>mdx:</italic>MuSC<italic>-Flt1<sup>+/+</sup></italic> mouse TA muscle. Data show mean ± SD (n=3). (n=3). (<bold>F</bold>) Decreased grip strength normalized to body weight in <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> compared with the control <italic>mdx:</italic>MuSC<italic>-Flt1<sup>+/+</sup></italic> mouse TA muscle at both 3 and 12 months of age. Data show mean ± SD (n=3). (<bold>G</bold>) Representative H&amp;E (scale bars, 100 µm), Sirus red stain staining (red; scale bars, 100 µm) and CD31(+) capillaries (green; scale bar, 25 µm) from TA muscle of <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> and <italic>mdx:Vegfa<sup>+/+</sup></italic> mouse at 3 months. (<bold>H</bold>) Increased average fiber size in <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> compared with the control <italic>mdx:Vegfa<sup>+/+</sup></italic> mouse TA and diaphragm (DM) muscle. Data show mean ± SD (n=3). (<bold>I</bold>) Decreased fibrosis in <italic>mdx: Vegfa<sup>+/</sup></italic><sup>Hyper</sup> compared with the control <italic>mdx:Vegfa<sup>+/+</sup></italic> mouse TA muscle and diaphragm (DM) muscle. Data show mean ± SD (n=4 to 8). (<bold>J</bold>) Muscle perfusion is increased in <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> compared with the control <italic>mdx:Vegfa<sup>+/+</sup></italic> mouse TA muscle. Data show mean ± SD (n=3). (<bold>K</bold>) Grip strength normalized to body weight is increased in <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> compared with the control <italic>mdx:Vegfa<sup>+/+</sup></italic> mice. Data show mean ± SD (n=3).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Measurement of VEGFA-FLT1 pathway in MuSCs for muscle pathology in DMD model mice.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>VEGFA-FLT1 pathway in MuSCs for muscle pathology in DMD model mice.</title><p>(<bold>A</bold>) Heatmap of microarray data profiling <italic>Vegfa</italic> ligands and receptors in mouse MuSC cultures (left), whole muscle in animal models (middle) and huma patient biopsy samples (right). (<bold>B</bold>) Body mass is preserved in <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> compared with the control <italic>mdx:MuSC-Flt1<sup>+/+</sup></italic> mice at both 3 and 12 months of age. Data show mean ± SD (n=4). (<bold>C</bold>) Fiber size distribution of <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> compared with the control <italic>mdx:</italic>MuSC<italic>-Flt1<sup>+/+</sup></italic> mouse TA muscle shows a small decrease in fiber size at 12 months of age. Data show mean ± SD (n=4). (<bold>D</bold>) CD31(+) capillaries shown in <xref ref-type="fig" rid="fig4">Figure 4B and G</xref> are slightly decreased in <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mice but increased in <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice compared with the control <italic>mdx:</italic>MuSC<italic>-Flt1<sup>+/+</sup></italic> mice or <italic>mdx:Vegfa<sup>+/+</sup></italic> mice at 12 months of age. Data show mean ± SD (n=4). (<bold>E</bold>) Body mass is preserved in <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> compared with the control <italic>mdx:Vegfa<sup>+/+</sup></italic> mice at 12 months of age. Data show mean ± SD (n=3). (<bold>F</bold>) Fiber size distribution of <italic>mdx:Vegfa<sup>+/</sup></italic><sup>a</sup> compared with the control <italic>mdx:Vegfa<sup>+/+</sup></italic> mice TA and diaphragm (DM) muscle shows a small increase in fiber size at 12 months of age. Data show mean ± SD (n=3).</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Measurement of VEGFA-FLT1 pathway in MuSCs for muscle pathology in DMD model mice.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>VEGFA-FLT1 pathway in MuSCs regulates apoptotic cell death in DMD model mice.</title><p>(<bold>A</bold>) Experimental schema detailing the experiments performed in this figure. The <italic>mdx:Vegf<sup>+/</sup></italic><sup>Hyper</sup><italic>:Pax7<sup>tdT</sup></italic> was pulsed with TMX to label Pax7-tdTomato(+) MuSCs prior to investigation. Three days following BaCl<sub>2</sub> injection, TA muscle was harvested for apoptotic cell death detection. (<bold>B</bold>) Caspase-3 (+) (Cas-3, green) apoptotic cells in theta muscle of the <italic>mdx:Vegfa<sup>+/+</sup>:Pax7<sup>tdT</sup></italic> and <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup><italic>:Pax7<sup>tdT</sup></italic> mice. Red and blue staining show Pax7-tdTomato and DAPI staining. Scale bar indicates 25 µm. (<bold>C</bold>) Caspase-3(+) apoptotic cells were decreased in Pax7-tdTomato(+) MuSCs in the TA muscle of <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup><italic>:Pax7<sup>tdT</sup></italic> mice compared with control <italic>Vegfa<sup>+/+</sup>:Pax7<sup>tdT</sup></italic> mice 3 days following muscle injury. Data show mean ± SD (n=4).</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Measurement of apoptotic cell death.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-73592-fig4-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-73592-fig4-figsupp2-v2.tif"/></fig></fig-group><p>By contrast, when we crossed the <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice with <italic>mdx</italic> mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), we noticed a significant increase in fiber diameter, increase in capillary density and decreased fibrosis (<xref ref-type="fig" rid="fig4">Figure 4G–I</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D–F</xref>) in both TA and diaphragm muscle of <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice. This was accompanied by a physiological increase in muscle perfusion as shown by laser Doppler flow at 12 months age (<xref ref-type="fig" rid="fig4">Figure 4J</xref>) as well as a functional increase in muscle strength as judged by grip strength (<xref ref-type="fig" rid="fig4">Figure 4K</xref>) without a change in body mass (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>). Lastly, when the muscle was injured acutely, with BaCl<sub>2</sub>, the <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mouse had lower number of apoptotic MuSC (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A–C</xref>). These data indicate that VEGFA-FLT1 axis is a therapeutic target for the pathology seen in the DMD model <italic>mdx</italic> mice.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this report, we performed bulk and single cell RNA sequencing on MuSCs and ECs. Since deep reads can significantly reduce the effect of the technical noise in scRNA-seq, it can improve estimation of minor transcriptional state of a given cell (<xref ref-type="bibr" rid="bib102">Zhang et al., 2020</xref>). Unexpectedly, we found that MuSCs broadly express EC prototypic markers in small amounts and used multiple different bioinformatics techniques to validate the results. While similar phenomenon in myogenic cells during development and existence of blood-vessel-associated myoendothelial cells in the adult skeletal muscle have been previously described, no functional follow up as been performed leading to the questions whether these minor expression profiles were artifacts or functional (<xref ref-type="bibr" rid="bib17">De Angelis et al., 1999</xref>; <xref ref-type="bibr" rid="bib60">Minasi et al., 2002</xref>; <xref ref-type="bibr" rid="bib81">Tamaki et al., 2002</xref>; <xref ref-type="bibr" rid="bib103">Zheng et al., 2007</xref>; <xref ref-type="bibr" rid="bib74">Roobrouck et al., 2011</xref>; <xref ref-type="bibr" rid="bib37">Huang et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Charville et al., 2015</xref>; <xref ref-type="bibr" rid="bib32">Goel et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Giordani et al., 2019</xref>). Our goal was to see whether this small expression pattern had biological consequences. We ultimately decided to use <italic>Flt1</italic> for further investigations and used RNAscope and immunostaining to validate its expression in MuSCs. We found that <italic>Flt1</italic> indeed exerts a biological function even at a low expression. Signaling through VEGFA-FLT1-AKT1 can improve cell survival in MuSCs both in vivo and in vitro.</p><p>On a grander scale, our finding of EC prototype markers expressed in MuSC calls into two questions (1) the genes that we used to specify cellular identities and (2) the cellular identity of MuSCs and ECs. The former is important as when we experimentally label, induce or perform Cre-mediated gene knockout experiments based on our assumptions of different gene expression results which may be confounded for these low expressing genes. For example, we have previously investigated both <italic>Flt1</italic> and <italic>Kdr</italic> in mouse muscle using three different reporters and found them to be negative in MuSCs, thereby disregarding their cell-autonomous effect when evaluating global knockouts (<xref ref-type="bibr" rid="bib90">Verma et al., 2010</xref>; <xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>). It is also possible that EC mRNAs are results of transcription from the cell or a result of mRNA transfer from neighboring cells (<xref ref-type="bibr" rid="bib20">Desrochers et al., 2016</xref>). Of note, the transmission of <italic>tdTomato</italic> mRNA and protein from <italic>Pax7<sup>+/CreERT2</sup>:R26R<sup>+/tdT</sup></italic>mice used in this study has been recently shown via exosome, opening up the possibility of transmission of other mRNA from MuSC to ECs (<xref ref-type="bibr" rid="bib65">Murach et al., 2020</xref>). The later is an interesting phenomenon form a developmental point of view. MuSCs and ECs arise from a bipotent progenitor originated from somites during early development (<xref ref-type="bibr" rid="bib40">Kardon et al., 2002</xref>; <xref ref-type="bibr" rid="bib38">Hutcheson and Kardon, 2009</xref>; <xref ref-type="bibr" rid="bib44">Lagha et al., 2009</xref>; <xref ref-type="bibr" rid="bib56">Mayeuf-Louchart et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Mayeuf-Louchart et al., 2016</xref>). Therefore, it is possible that there is a permissive chromatin state that allows for expression of reciprocal genes in the two populations. Along the lines of these observations, FLK1(+) or VE-cadherin(+) cells can contribute to myogenic cells in vitro and after cell transplantation (<xref ref-type="bibr" rid="bib81">Tamaki et al., 2002</xref>; <xref ref-type="bibr" rid="bib47">Le Grand et al., 2004</xref>; <xref ref-type="bibr" rid="bib103">Zheng et al., 2007</xref>; <xref ref-type="bibr" rid="bib37">Huang et al., 2014</xref>), and during development (<xref ref-type="bibr" rid="bib64">Motoike et al., 2003</xref>; <xref ref-type="bibr" rid="bib56">Mayeuf-Louchart et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Drummond and Hatley, 2018</xref>). Important notion is that the PDGFRα(-)FLK1(+) population exhibited restricted potential to differentiate into the MuSCs in injured muscle (<xref ref-type="bibr" rid="bib77">Sakurai et al., 2008</xref>). Interestingly, in the zebrafish, exogenous expression of <italic>Etv2</italic> in the fast muscle can lead to transdifferentiation of muscle fibers into functional vessels so there is evidence of cell fate flexibility (<xref ref-type="bibr" rid="bib88">Veldman et al., 2013</xref>). The potential of EC transdifferentiation was also examined by ETV2 overexpression in five human cell types, skeletal muscle cells, adipose-derived mesenchymal stem cells, umbilical-cord-derived mesenchymal stem cells, embryonic lung fibroblast cells, and skin fibroblast cells. Among them, human skeletal muscle cells showed the highest amenability for this EC induction following infection with ETV2 lentivirus vector (<xref ref-type="bibr" rid="bib99">Yan et al., 2019</xref>). Conversely, <italic>Etv2</italic>-deficient vascular progenitors can differentiate into skeletal muscle cells (<xref ref-type="bibr" rid="bib15">Chestnut et al., 2020</xref>). It would be interesting to see whether other EC gene signatures also have functional consequences in the MuSC or muscle at large.</p><p>We decided to focus on function of <italic>Flt1</italic> among several EC genes expressed in MuSCs for further investigations on MuSC biology. Our pharmacological and genetic analyses demonstrate that MuSC-derived VEGFA has a drastic effect on cell survival in the via its receptor FLT1 by signaling through AKT1. While VEGFA binds to both FLT1 and FLK1, VEGFB and PGF only bind to FLT1. This creates a scenario where PGF and VEGFB binding can sequester FLT1, increasing free VEGFA availability for VEGFA-FLK1 binding which is the major VEGF signaling pathway for many cell types (<xref ref-type="bibr" rid="bib89">Vempati et al., 2014</xref>). While PGF is not normally expressed in adult tissues, VEGFB is expressed in the MuSCs and muscle fiber (data not shown). Importantly, the VEGFB-FLT1 axis has also been shown to inhibit apoptosis in retina and brain cells in mouse models of ocular neurodegeneration and stroke (<xref ref-type="bibr" rid="bib49">Li et al., 2008</xref>). While our results cannot rule out the involvement of VEGFB in protection of MuSC apoptosis, we provide evidence from both pharmacological and genetic data to indicate that VEGFA is involved.</p><p>Despite drastic effect of VEGFA-FLT1 on apoptosis in vitro, the long-term consequences of in vivo deletion of <italic>Flt1</italic> in the MuSC compartment were modest compared with deletion of <italic>Vegfa</italic> in the MuSCs unless crossing with <italic>mdx</italic> mice. Although <italic>Vegfa</italic> is required for both MuSC survival and recruitment of vascular niche (<xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>), in the steady state, the MuSC turnover may be low enough that the apoptotic stress burden is low. We demonstrated that VEGFA improves cell survival during the proliferative stage following injury in <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hype<italic>r</italic></sup> mice. The evidence that MuSC survival is impaired comes indirectly from transplantation experiments where MuSCs obtained from <italic>mdx</italic> mice engraft to a much lesser degree than those from WT mice (<xref ref-type="bibr" rid="bib7">Boldrin et al., 2015</xref>).</p><p>During the review process of this paper, two additional labs reported complementary findings about VEGFA signaling in MuSC (<xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>; <xref ref-type="bibr" rid="bib33">Groppa et al., 2023</xref>). Groppa et al performed extensive transcriptomics to show role of the VEGFA system in muscle regeneration. They showed that VEGFA is expressed in expression in MuSC and inflammatory cells. In addition, VEGFA increased MuSC proliferation through KDR (FLK1). They also found that deletion of MuSC derived VEGFA lead to an increase in TUNEL(+) apoptotic MuSC. The role of KDR in MuSC was also corroborated by Chen et.al who showed that MuSC lacking KDR showed asymmetrical division deficits and limit MuSC proliferation resulting in impaired tissue regeneration. While both these reports focus on the role of VEGFA-KDR on proliferation, the current paper focuses on the role of VEGFA-FLT1 on MuSC survival.</p><p>VEGFA and FLT1 targeted therapies are being explored as both pro- and anti-angiogenic therapies for several indications including retinal degeneration, cancer, pre-eclampsia, and neuromuscular diseases (<xref ref-type="bibr" rid="bib5">Bae et al., 2005</xref>; <xref ref-type="bibr" rid="bib90">Verma et al., 2010</xref>; <xref ref-type="bibr" rid="bib54">Mac Gabhann et al., 2010</xref>; <xref ref-type="bibr" rid="bib41">Keifer et al., 2014</xref>; <xref ref-type="bibr" rid="bib92">Verma et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Bosco et al., 2021</xref>; <xref ref-type="bibr" rid="bib97">Xin et al., 2021</xref>). As these therapies mature, it will be important to ascertain the MuSC-specific effects of VEGFA and FLT1.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p><italic>Flt1<sup>LoxP/LoxP</sup></italic> were obtained from Gua-Hua Fong (<xref ref-type="bibr" rid="bib36">Ho et al., 2012</xref>). <italic>B6.Cg-Pax7<sup>tm1(cre/ERT2)Gaka/J</sup></italic> (<italic>Pax7<sup>+/CreERT2</sup></italic>; JAX stock# 017763; <xref ref-type="bibr" rid="bib66">Murphy et al., 2011</xref>), <italic>B6.Cg-Gt(ROSA)<sup>26Sortm9(CAG-tdTomato)Hze/J</sup></italic> (<italic>Ai9</italic>; JAX stock # 007909; <xref ref-type="bibr" rid="bib55">Madisen et al., 2010</xref>), <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> (<italic>Vegfatm1.1Nagy/J</italic>; JAX stock# 027314; <xref ref-type="bibr" rid="bib61">Miquerol et al., 1999</xref>) and <italic>B6Ros.Cg-Dmd<sup>mdx-5cv</sup>/J</italic> (<italic>mdx<sup>5cv</sup></italic>; JAX stock #002379; <xref ref-type="bibr" rid="bib11">Chapman et al., 1989</xref>) were obtained from Jackson Laboratory. <italic>Kdr<sup>tm2.1Jrt/J</sup></italic> (<italic>Flk1<sup>+/GFP</sup></italic>) were obtained from Masatsugu Ema (<xref ref-type="bibr" rid="bib24">Ema et al., 2006</xref>). <italic>B6.Cg-Pax7<sup>tm1(cre/ERT2)Gaka/J</sup></italic> (<italic>Pax7<sup>+/CreERT2</sup></italic>) mice were crossed with the <italic>B6.Cg-Gt(ROSA)<sup>26Sortm9(CAG-tdTomato)Hze/J</sup></italic> (<italic>Ai9</italic>) to yield the <italic>Pax7<sup>+/CreERT2</sup>:R26R<sup>tdT</sup></italic>(<italic>Pax7<sup>tdT</sup></italic>) mice. <italic>Pax7<sup>tdT</sup></italic> mice were bred with the <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> and <italic>Flk1<sup>+/GFP</sup></italic> to obtain <italic>Pax7<sup>+/tdT</sup>:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> and <italic>Pax7<sup>+/tdT</sup>:Flk1<sup>+/GFP</sup></italic> mice. <italic>Vegfa<sup>LoxP/LoxP</sup></italic> mice obtained from Napoleone Ferrara (<xref ref-type="bibr" rid="bib29">Gerber et al., 1999</xref>) were crossed with <italic>Pax7<sup>+/CreERT2</sup></italic> to yield the <italic>Pax7<sup>+/CreERT</sup>: Vegfa<sup>LoxP/LoxP</sup></italic> mice. <italic>Flt1<sup>LoxP/LoxP</sup></italic> mice obtained from Guo-Hua Fong (<xref ref-type="bibr" rid="bib29">Gerber et al., 1999</xref>) were crossed with <italic>Pax7<sup>+/CreERT2</sup></italic> to yield the <italic>Pax7<sup>+/CreERT</sup>:Flt1<sup>LoxP/LoxP</sup></italic> mice. Colonies for all the mice were established in the laboratory. Cre recombination was induced using tamoxifen (T5648, MilliporeSigma) dosed as 75 mg/kg body weight x 3 times over 1 week at 3–6 weeks of age. Mice carrying the wild-type <italic>CreERT2</italic> allele were used for control experiments. TA muscle regeneration was induced by intramuscular injection of 20 µl of 1% BaCl<sub>2</sub> (342920, MilliporeSigma) or 20 µl of 10 µM Cardiotoxin (CTX) (V9125, MilliporeSigma). Mice used for this study is summarized in Key Resources Table.</p><p>Genotyping to detect the transgenic and mutant alleles was performed by PCR using the primers described on the web site of Jackson Laboratory shown in Key Resources Table. All primers were synthesized as custom DNA oligos from Integrated DNA technologies (IDT). Genotyping to detect the mutated allele of <italic>mdx<sup>5cv</sup></italic> was performed by PCR using the primers (0981 and 0982) shown in Key Resources Table. The PCR product DNA was digested with <italic>Dra</italic>III restriction enzyme (R3510S, New England Biolabs). Wild-type allele generated 180 bp and mutant allele generated 50 and 130 bp bands.</p><p>The animals were housed in an SPF environment and were monitored by the Research Animal Resources (RAR) of the University of Minnesota. All protocols (2204–39969A) were approved by the Institutional Animal Care and Usage Committee (IACUC) of the University of Minnesota and complied with the NIH guidelines for the use of animals in research.</p></sec><sec id="s4-2"><title>Cell isolation by FACS</title><p><italic>Pax7<sup>tdT</sup>:Flk1<sup>GFP</sup></italic> mice were utilized for FACS-mediated MuSC and EC isolation as previously described (<xref ref-type="bibr" rid="bib4">Asakura et al., 2002</xref>; <xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>). We performed extensive validation of the fluorescent reporter mice as previously described (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–C</xref>; <xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>). Briefly, quiescent MuSCs and ECs were isolated from the hind limb skeletal muscle of 1- to 2-month-old <italic>Pax7<sup>tdT</sup>:Flk1<sup>GFP</sup></italic> mice after digestion with collagenase type II. FACS was performed on an FACS sorter (BD FACSAria) and data were analyzed using FlowJo (BD Biosciences). Sorting gates, tdTomato(+) for MuSCs and GFP(+) for ECs, were strictly defined based on control cells isolated from wild-type mice and the forward scatter and side scatter gating. Sorted cells were immediately characterized by immunostaining on slide glasses, utilized for RNA preparation or cultured on collagen-coated plates in the myoblast growth medium as below to obtain MuSC-derived myoblasts and ECs. FACS analysis was performed as previously described (<xref ref-type="bibr" rid="bib86">Turaç et al., 2013</xref>). Cells were either trypsinized (cultured cells) or a single cell suspension was obtained following enzymatic digestion as whole muscle-derived cells (<xref ref-type="bibr" rid="bib3">Asakura et al., 2001</xref>; <xref ref-type="bibr" rid="bib4">Asakura et al., 2002</xref>). Cells were then washed with FACS buffer (2% BSA and 1 mM EDTA in PBS) followed by live/dead staining using ZombieNIR (423105, Biolegends). Cells were washed, then immunostained for cell surface markers. Blocking cells was performed with 1% BSA/PBS, and cells were incubated in fluorescently-conjugated antibody. FACS was performed on a Fortessa X-20 (BD Biosciences) with a 355 nm, 405 nm, 488 nm, 561 nm, and 640 nm lasers.</p></sec><sec id="s4-3"><title>Cell culture</title><p>Mouse bEnd.3 EC cells (CRL-229), C166 EC cells (CRL-2581), and C2C12 myoblast cells (CRL-1772) were obtained from American Type Culture Collection (ATCC). Human 293 FT cells (R70007) were obtained from ThermoFisher Scientific. All cell lines were cultured in DMEM medium with 10% FBS, 100 units/ml of penicillin, and 100 μg of streptomycin at 37 °C in 5% O<sub>2</sub> and 5% CO<sub>2</sub>. All cell lines were STR profiled to confirm their identity and tested negative for mycoplasma. MuSC-derived myoblast isolation from adult mice was performed as previously described (<xref ref-type="bibr" rid="bib63">Motohashi et al., 2014</xref>). Briefly, after collagenase type II (CLS-2, Worthington) treatment, dissociated cells from mouse hindlimb muscle were incubated with anti-CD31-PE (12-0311-82, eBiosciences), anti-CD45-PE (12-0451-81, eBiosciences), anti-Sca1-PE (A18486, eBiosciences) and anti-Integrin α7 (ABIN487462, MBL International), followed by anti-PE microbeads (130-048-801, Miltenyi Biotec), and then performed LD column (130-042-901, Miltenyi Biotec) separation. Negative cell populations will be incubated with anti-Mouse IgG beads (130-048-402, Miltenyi Biotec), and then MS column (130-042-201, Miltenyi Biotec) separation was performed to isolate Integrin α7(+) MuSCs. MuSC-derived myoblasts were maintained in culture on collagen coated plates in myoblast medium containing 20% FBS, 20 ng/ml bFGF (PHG0263, Invitrogen), 100 units/ml of penicillin and 100 μg of streptomycin in HAM’s-F10 medium. Cell cultures were maintained in a humidified incubator at 37 °C with 5% CO<sub>2</sub> and 5% O<sub>2</sub>. 4-Hydroxy tamoxifen (4-OHT, H6278, MilliporeSigma) treatment (1 µM in EtOH) was used to induce <italic>Flt1</italic> deletion in myoblasts isolated from <italic>Flt1<sup>LoxP/LoxP</sup>:Pax7<sup>CreERT2</sup></italic> mice. For cell survival assay, 1 x 10<sup>5</sup> cells were allowed to adhere for 1 day and starved overnight in 0.1% FBS in HAM’s F10 medium. Then, cells were exposed to 1 µM EdU along with or without 2–100 ng/ml recombinant VEGFA (493 MV, R&amp;D Systems) for 8 hr before being fixed and stained by the Click-iT EdU Alexa Fluor 488 Imaging Kit (C10337, Thermo Fisher Scientific). For induction of apoptosis in myoblasts, (1–2 x 10<sup>5</sup>) cells were allowed to adhere to the plates for 16 hr. Thapsigargin-mediated apoptosis was induced by 1 µM of thapsigargin (T9033, MilliporeSigma) dissolved in EtOH with or without VEGFA, 100 ng/ml recombinant FLT1-FC (7756-FL, R&amp;D Systems), 1 µg/ml anti-FLT1 monoclonal antibody (Angio-Proteomie, MAB7072), inhibitors of FLK1, 3 µM ZM306416 (2499/1, R&amp;D Systems) and 10 µM of SU5402 (3300/1, R&amp;D Systems) and an inhibitor of NRP1, 30 µM of EG00229 (6986/10, R&amp;D Systems) for 24 hours. UV light-mediated apoptosis was induced by exposing the cells to UV light in cell culture hood for 45 s without medium. After UV exposure, cell survival was assessed 24 hr following culture in 0.1% FBS in HAM’s F10 medium with or without VEGFA using the Crystal violet Assay Kit (ab232855, Abcam) and quantified the Crystal violet dye after solubilization by absorbance at 570 nm. To induce differentiation of myoblasts, the myoblast medium was replaced with differentiation medium that contained DMEM supplemented with 5% horse serum with or without VEGFA or bFGF for 1 or 3 days followed by anti-sarcomeric myosin heavy chain antibody (MF-20, Developmental Study Hybridoma Bank).</p></sec><sec id="s4-4"><title>AKT1 induction</title><p>The lentiviral pCCL-E4ORF1 and pCCL-myrAkt1 constructs were a kind gift from Dr. Jason Butler (<xref ref-type="bibr" rid="bib42">Kobayashi et al., 2010</xref>). A total of 293 FT cells (R70007, Thermo Fisher Scientific) were seeded in DMEM with 10% FBS and transfected with the lentivirus vectors along with pCMV-VSV-G (8454, Addgene), pRSV-Rev (12253, Addgene), and pMDLg/pRRE (12251, Addgene) using PolyJet transfection reagent (SL100688, Signagen Laboratories). The culture supernatant of the transfected 293 FT cells was added to MuSC-derived myoblast culture with 0.8 μg/ml polybrene (MilliporeSigma, H9268). pAKT1(+) cells were stained with anti-pAKT1 antibody (4060, Cell Signaling).</p></sec><sec id="s4-5"><title>Western blotting</title><p>Protein extracts of MuSC-derived myoblast culture obtained with an NE-PER Nuclear and Cytoplasmic Extraction reagents (78833, Thermo Fisher Scientific) was used for western blotting. Protein concentration was determined by the Micro BCA Protein Assay Reagent kit (Thermo Fisher Scientific). Following electrophoresis, the proteins were transferred to an Immobilon P membrane (IPVH00010, EMD Millipore) overnight. pAKT1 was detected by Western blotting with anti-pAKT1 antibody (4060, Cell Signaling) followed by anti–rabbit IgG HRP (31460, Cell Signaling Technology). To verify equal loading proteins, the same blots were stripped and reprobed with anti-GAPDH HRP conjugated (3683, Cell Signaling) as a cytosolic marker. The reaction was developed using SuperSignal West Femto chemiluminescent substrate (PI37074, Fisher Scientific) in accordance with the manufacturer’s instructions. Protein signals were detected and quantitated by iBright FL1500 (A44241, ThermoFisher Scientific).</p></sec><sec id="s4-6"><title>Apoptosis assay</title><p>Apoptosis was measured using measured using Annexin V-Biotin Apoptosis Detection Kit (BMS500BT-100, eBioscience) as per the manufacture’s instruction. Streptavidin-conjugated Alexa-Fluro-488 was used for detection. Propidium Iodide (PI) was used in all assays except when Pax7tdT(+) cells were utilized or when ZombieNIR (423105, Biolegends) was used. FACS was performed on a Fortessa X-20 (BD Biosciences) equipped with a 355 nm, 405 nm, 488 nm, 561 nm, and 640 nm lasers. For detection of apoptotic cells in TA muscle sections 3 days following BaCl<sub>2</sub> injection, TMX was injected into <italic>mdx:Vegfa<sup>+/+</sup>:Pax7<sup>tdT</sup></italic> and <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup><italic>:Pax7<sup>tdT</sup></italic> mice before BaCl<sub>2</sub> injection to label MuSCs during muscle regeneration. To detect apoptotic cells, the TA muscle sections were incubated with anti–activated caspase-3 antibody (ab214430, Abcam) followed by anti–rabbit Alexa-488 antibodies (A11008, ThermoFisher Scientific) for double immunostaining. DAPI (10236276001, MilliporeSigma) was used for counterstaining of nuclei. Microscopic images were captured by a DP-1 digital camera attached to BX51 fluorescence microscope with 10×, 20×or 40×UPlanFLN objectives with cellSens Entry 1.11 (all from Olympus).</p></sec><sec id="s4-7"><title>Immunostaining of cells</title><p>Immunostaining for PECAM1, VE-Cadherin, VEGFA, VEGFRs was performed on collagen coated coverslips. Other immunostaining was performed on 35 mm tissue culture plates. Cells were fixed with 2% PFA for 5 min and immunostained as previously described (<xref ref-type="bibr" rid="bib90">Verma et al., 2010</xref>). For membrane receptor staining, cells were permeabilized with 0.01% saponin (ICN10285525, ThermoFisher Scientific) which was kept in the staining solution until the primary antibodies were washed off. At which time, 0.01% Triton-X was added to all the buffers. The antibodies used for this study are listed in Key Resources Table.</p></sec><sec id="s4-8"><title>Single muscle fiber isolation and staining</title><p>Extensor digitorum longus (EDL) muscle was dissected and digested with 0.2% collagenase type I (C0130, MilliporeSigma) for single muscle fiber isolation as previously described (<xref ref-type="bibr" rid="bib90">Verma et al., 2010</xref>). Single muscle fibers were fixed with 2% PFA/PBS, permeabilized with 0.2% Triton-X100 and counterstained with DAPI. Anti-Pax7 antibody(+) or tdTomato(+) MuSCs per single muscle fiber were counted manually.</p></sec><sec id="s4-9"><title>RNAscope</title><p>RNAscope for <italic>Flt1</italic> transcripts was performed as previously described (<xref ref-type="bibr" rid="bib39">Kann and Krauss, 2019</xref>) on single muscle fibers from <italic>Pax7<sup>tdT</sup></italic> mice using the RNAscope Probe - Mm-Flt1 (C1) (415541, ACDBio). Briefly, isolated EDL fibers are fixed in 4% PFA, washed with PBS, and dehydrated in 100% methanol. Subsequently, fibers are rehydrated in a stepwise gradient of decreasing methanol concentrations in PBS/0.1% Tween-20. Fibers are treated with a proteinase for 10 min, followed by hybridization, amplification, and fluorophore conjugation steps.</p></sec><sec id="s4-10"><title>Histology and immunostaining for sections</title><p>The mouse tibialis anterior (TA) muscle was used for all histological analysis. Tissues were frozen fresh using LiN<sub>2</sub> chilled isopentane and stored at –80 °C. Eight μm thick transverse cryosections were used for all histological analysis. Hematoxylin &amp; Eosin (HE) staining were performed as previously described (<xref ref-type="bibr" rid="bib90">Verma et al., 2010</xref>). Sirius red (Direct Red 80, 365548, MilliporeSigma) staining was performed for muscle sections for fibrosis as previously described (<xref ref-type="bibr" rid="bib79">Shimizu-Motohashi et al., 2015</xref>). Muscle sections were stained in Oil Red O solution (O1391-250ML, MilliporeSigma) as previously described (<xref ref-type="bibr" rid="bib96">Wang et al., 2017</xref>). Anti-eMHC (F1.652, Developmental Study Hybridoma Bank) and anti-Laminin (L0663, MilliporeSigma) antibodies followed by anti-mouse Alexa-488 (A11001, ThermoFisher Scientific) and anti-rat Alexa-568 antibodies (A11077, ThermoFisher Scientific) were used for detection of regenerating muscle fibers. For capillary density measurement, anti-CD31 antibody (550274, BD Biosciences) was used for TA muscle sections followed by anti-rat Alexa-488 (A11006, ThermoFisher Scientific). Microscopic images were captured by a DP-1 digital camera attached to BX51 fluorescence microscope with 10×, 20×or 40×UPlanFLN objectives with cellSens Entry 1.11 (all from Olympus). Photoshop (Adobe) and Fiji (NIH) were used for image processing and manually enumerating the fiber feret’s diameter (<xref ref-type="bibr" rid="bib78">Schindelin et al., 2012</xref>).</p></sec><sec id="s4-11"><title>Grip strength test</title><p>Forelimb grip strength test was performed following a previously published procedure (<xref ref-type="bibr" rid="bib1">Aartsma-Rus and van Putten, 2014</xref>). Briefly, mice were gently pulled by the tail after fore limb-grasping a metal bar attached to a force transducer (Grip Strength Meter, 1027CSM-D52, Columbus Instruments). Grip strength tests were performed by the same blinded examiner. Five consecutive grip strength tests were recorded, and then mice were returned to the cage for a resting period of 20 min. Then, three series of pulls were performed each followed by 20 min resting period. The average of the three highest values out of the 15 values collected was normalized to the body weight for comparison.</p></sec><sec id="s4-12"><title>Muscle perfusion</title><p>RBC flux was evaluated using the moorLabTM laser Doppler flow meter as previously described (<xref ref-type="bibr" rid="bib90">Verma et al., 2010</xref>) with the MP7a probe that allows for collecting light from a deeper tissue level than standard probes according to the manufacturer’s instructions (Moor Instruments). The fur from the right hind leg was removed using a chemical depilatory. Readings were taken using the probe from at least 10 different spots on the TA muscle. The AU was determined as the average AU value during a plateau phase of each measurement.</p></sec><sec id="s4-13"><title>RNA and genomic DNA isolation and qPCR</title><p>Cultured cells were washed with ice cold PBS and lysed on the place with Trizol. RNA was isolated using the DirectZol RNA Microprep Kit (R2062, Zymo Research) with on-column DNase digestion followed by cDNA synthesis using the Transcriptor First Strand cDNA synthesis kit (04379012001, Roche Molecular Diagnostics) using random primers. Genomic DNA for genotyping was isolated from mouse tail snips with lysis buffer containing Proteinase K (P2308, MilliporeSigma). qPCR was performed using GoTaq qPCR Master Mix (A6002, Promega). The input RNA amount was normalized across all samples and <italic>18 S rRNA</italic> or <italic>HtatsF1</italic> was used for normalization of qPCR across samples. Primer sequences are listed in Key Resources Table. All primers were synthesized as custom DNA oligos from Integrated DNA technologies (IDT).</p></sec><sec id="s4-14"><title>Single-cell RNA sequencing and analysis</title><p>Cells for single-cell RNA-seq (scRNA-seq) were obtained from hind limb muscles of 2–3 month-old <italic>Pax7<sup>tdT</sup>:Flk1<sup>GFP</sup></italic> mice following enzymatic digestion as previously described (<xref ref-type="bibr" rid="bib52">Liu et al., 2015</xref>). Dead cells were excluded from the analysis using ZombieNIR (423105, Biolegends). TdTomato(+) and GFP(+) cells were sorted individually and then 20% of GFP(+) cells were spiked into 80% tdTomato(+). We loaded ~5000 cells into 1 channel of the Chromium system for each of these samples and prepared libraries according to the manufacturer’s protocol using version 2.0 chemistry (10 x Genomics). Following capture and lysis, we synthesized cDNA and amplified for 12 cycles as per the manufacturer’s protocol (10 X Genomics). The amplified cDNA was used to construct Illumina sequencing libraries that were each sequenced with ~300 K read/cell on one lane of an Illumina HiSeq 2500 machine. We used Cell Ranger 3.1 (10X Genomics) to process raw sequencing data. For A custom genome was constructed to include <italic>eGFP-SV40</italic>, <italic>tdTomato-WPRE-BGHPolyA</italic> and <italic>Pax7-IRES-CreERT2</italic> transgenes. Detailed step-by-step instructions can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/verma014/10XCustomRef">https://github.com/verma014/10XCustomRef</ext-link>, (copy archived at <xref ref-type="bibr" rid="bib93">Verma, 2020</xref>). We carried out analyses of the filtered data using Seurat suite version 3.0 <xref ref-type="bibr" rid="bib80">Stuart et al., 2019</xref> in <xref ref-type="bibr" rid="bib75">RStudio Team, 2020</xref>. For cell imputation, we utilized ALRA through the Seurat wrapper with default settings (<xref ref-type="bibr" rid="bib50">Linderman et al., 2022</xref>). Additional scRNA-seq datasets were obtained from GEO and analyzed using the same method as listed above. A myogenic score was calculated based on the expression of <italic>Myog</italic>, <italic>Pax7</italic>, <italic>Myod1,</italic> and <italic>Myf5</italic>. Step-by-step instructions for the analysis can be found on <ext-link ext-link-type="uri" xlink:href="https://github.com/verma014/10XCustomRef">https://github.com/verma014/10XCustomRef</ext-link>, (copy archived at <xref ref-type="bibr" rid="bib93">Verma, 2020</xref>).</p></sec><sec id="s4-15"><title>Background subtraction</title><p>10 x Genomics scRNA-seq platform uses many more droplets than cells and so following a run, there are many droplets that do not have cells. These droplets still get sequenced with some of the RNA that is in the solution. This floating RNA can be used to estimate the ‘background’ in each droplet. A better description of this can be found by the developers of 'SoupX' (<xref ref-type="bibr" rid="bib100">Young and Behjati, 2020</xref>). Since <italic>Cdh5</italic> expression has previously been verified in MuSCs using RNAscope, we were able to use it as a positive control to remove the background or ‘soup’ from our data. If <italic>Cdh5</italic> is absent from MuSC, we know that the background subtraction was too aggressive and that subtracting the Soup is not reliable in our case. In addition, we know certain genes that are considered to be specific for MuSCs, muscle ECs or muscle fibers based on the bulk RNA-seq (<xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>). The top 5 genes that are specific to these population (and also detected by 10 x) were selected and used to show the background in our data set was 14.40% and 13.89% for the D0 and D3 dataset, respectively. The step-by-step instructions can be found on <ext-link ext-link-type="uri" xlink:href="https://github.com/verma014/10XCustomRef">https://github.com/verma014/10XCustomRef</ext-link>, (copy archived at <xref ref-type="bibr" rid="bib93">Verma, 2020</xref>).</p></sec><sec id="s4-16"><title>Bulk RNA-seq and microarray analysis</title><p>FASTQ files were downloaded from SRA using SRA-toolkit. Sequences were trimmed using trimmomatic to remove adapter contamination and low-quality reads. Trimmed sequences were mapped to mouse mm10 using Hisat2 (<xref ref-type="bibr" rid="bib71">Pertea et al., 2016</xref>). Transcript assembly was performed using StringTie (<xref ref-type="bibr" rid="bib71">Pertea et al., 2016</xref>). Cell type specificity was determined as previously described (<xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>). Microarray analysis was performed using the Affymetrix Transcriptome Analysis Console (TAC). Samples in each experiment were RNA normalized and the expression was acquired using the Affeymetrix Expression analysis console with gene level expression. Heatmaps were generated in Prism 9 (Graphpad, La Jolla, CA).</p></sec><sec id="s4-17"><title>Quantification and statistical analysis</title><p>Statistical analysis was performed using Prism 9 (Graphpad, La Jolla, CA) or RStudio (<xref ref-type="bibr" rid="bib75">RStudio Team, 2020</xref>). For comparison between two groups, an unpaired T-test was used. For comparison between multiple groups, a one-way ANOVA was used with multiple comparisons to the control. Distributions were compared using a chi-squared test. Graphing of the data was performed using Prism 9. Vector diagrams were modified using Graphic (Autodesk). All values are means ± SD unless noted otherwise. * indicates p&lt;0.05, ** indicates p&lt;0.01, *** indicates p&lt;0.001.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Funding acquisition, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The animals were housed in an SPF environment and were monitored by the Research Animal Resources (RAR) of the University of Minnesota. All protocols (2204-39969A) were approved by the Institutional Animal Care and Usage Committee (IACUC) of the University of Minnesota and complied with the NIH guidelines for the use of animals in research.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-73592-transrepform1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Gene Expression Omnibus (GEO) used for this paper was shown in this table, including their repositories and references.</title></caption><media xlink:href="elife-73592-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All the data was obtained from NCBI GEO. Microarrays of mouse MuSCs were obtained from GSE3483 (<xref ref-type="bibr" rid="bib26">Fukada et al., 2007</xref>). scRNA-seq of MuSCs and muscle ECs was performed in this study (GSE129057). scRNA-seq of whole muscle was obtained from GSE143437 (<xref ref-type="bibr" rid="bib19">De Micheli et al., 2020</xref>). Bulk RNA-seq of MuSCs, ECs and single muscle fibers was obtained from GSE108739 (<xref ref-type="bibr" rid="bib91">Verma et al., 2018</xref>) and GSE64379 (<xref ref-type="bibr" rid="bib76">Ryall et al., 2015</xref>). Bulk RNA-seq of TU-tagged RNA of MuSCs was obtained from GSE97399 (<xref ref-type="bibr" rid="bib87">van Velthoven et al., 2017</xref>). Bulk RNA-seq of fixed and unfixed MuSCs was obtained from GSE113631 (<xref ref-type="bibr" rid="bib101">Yue et al., 2020</xref>). Exercise, ALS, DMD, BMD, FSHD GSE3307, Early DMD GSE465, mdx GSE466, GRMD GSE69040, MuSCs GSE15155. All arrays were normalized to their respective controls. All arrays and RNA-seq data are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1.</xref></p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Single-cell skeletal muscle satellite cells and endothelial cells during homeostasis and regeneration</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE129057">GSE129057</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Cosgrove</surname><given-names>BD</given-names></name><name><surname>De Micheli</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Single-cell transcriptomic atlas of the mouse regenerating muscle tissue</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE143437">GSE143437</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Skeletal muscle satellite cells, endothelial cells and single muscle fibers</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108739">GSE108739</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Ryall</surname><given-names>JG</given-names></name><name><surname>Dell'Orso</surname><given-names>S</given-names></name><name><surname>Derfoul</surname><given-names>A</given-names></name><name><surname>Juan</surname><given-names>A</given-names></name><name><surname>Zare</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Clermont</surname><given-names>D</given-names></name><name><surname>Koulnis</surname><given-names>M</given-names></name><name><surname>Gutierrez-Cruz</surname><given-names>G</given-names></name><name><surname>Fulco</surname><given-names>M</given-names></name><name><surname>Sartorelli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>The NAD+-Dependent SIRT1 Deacetylase Translates a Metabolic Switch into Regulatory Epigenetics in Skeletal Muscle Stem Cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64379">GSE64379</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Rando</surname><given-names>TA</given-names></name><name><surname>van Velthoven</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Transcriptional profiling of quiescent muscle stem cells in vivo</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97399">GSE97399</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>L</given-names></name><name><surname>Wan</surname><given-names>R</given-names></name><name><surname>Cheung</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Transcriptome profiling of quiescent muscle stem cells in vivo</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113631">GSE113631</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset7"><person-group person-group-type="author"><name><surname>Fukada</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><data-title>Genome-wide expression analysis of satellite cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE3483">GSE3483</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset8"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2005">2005</year><data-title>Comparative profiling in 13 muscle disease groups</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE3307">GSE3307</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset9"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Borup</surname><given-names>R</given-names></name><name><surname>Hoffman</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2003">2003</year><data-title>Expression profiling in the muscular dystrophies</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE465">GSE465</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset10"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>BS</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Pattison</surname><given-names>JS</given-names></name><name><surname>Gordon</surname><given-names>SE</given-names></name><name><surname>Granchelli</surname><given-names>JA</given-names></name><name><surname>Madsen</surname><given-names>RW</given-names></name><name><surname>Folk</surname><given-names>LC</given-names></name><name><surname>Hoffman</surname><given-names>EP</given-names></name><name><surname>Booth</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="2003">2003</year><data-title>mRNA expression in regenerated mdx mouse skeletal muscle</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE466">GSE466</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset11"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>YB</given-names></name><name><surname>Vieira</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Duchene Muscular Dystrophy Dogs Escapers and Affected Muscle Dogs Compared to Normal Dogs</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69040">GSE69040</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset12"><person-group person-group-type="author"><name><surname>Pallafacchina</surname><given-names>G</given-names></name><name><surname>Montarras</surname><given-names>D</given-names></name><name><surname>Regnault</surname><given-names>B</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><data-title>Gene profiling of quiescent and activated skeletal muscle satellite cells by an in vivo approach</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15155">GSE15155</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Minnesota Supercomputing Institute (MSI), University of Minnesota Imaging Center (UIC), University of Minnesota FACS Facility, and University of Minnesota Genomics Center (UMGC) for providing data for this paper. We also thank Jake Trask for critical reading of this paper. We thank Drs. Yosuke Mukouyama (National Institute of Health), Napoleone Ferrara (Genentech), Guo-Hua Fong (University of Connecticut) and Masatsugu Ema (Siga University of Medical Science) for providing <italic>Vegfa<sup>LoxP/LoxP</sup></italic>, <italic>Flt1<sup>LoxP/LoxP</sup></italic> and <italic>Flk1-GFP</italic> mice, respectively. This work was supported by NIHT32-GM008244 and NIHF30AR066454 to MV, NIAMS grant AR070231 to RSK, a fellowship of the Training Program in Stem Cell Research from the New York State Department of Health to A.P.K. (NYSTEM-C32561GG) and NIHR01AR062142, NIHR21AR070319, MDA Research Grant, and Regenerative Medicine Minnesota (RMM) Grant to AA.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aartsma-Rus</surname><given-names>A</given-names></name><name><surname>van Putten</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Assessing functional performance in the mdx mouse model</article-title><source>Journal of Visualized Experiments</source><volume>01</volume><elocation-id>51303</elocation-id><pub-id pub-id-type="doi">10.3791/51303</pub-id><pub-id pub-id-type="pmid">24747372</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arsic</surname><given-names>N</given-names></name><name><surname>Zacchigna</surname><given-names>S</given-names></name><name><surname>Zentilin</surname><given-names>L</given-names></name><name><surname>Ramirez-Correa</surname><given-names>G</given-names></name><name><surname>Pattarini</surname><given-names>L</given-names></name><name><surname>Salvi</surname><given-names>A</given-names></name><name><surname>Sinagra</surname><given-names>G</given-names></name><name><surname>Giacca</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo</article-title><source>Molecular Therapy</source><volume>10</volume><fpage>844</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1016/j.ymthe.2004.08.007</pub-id><pub-id pub-id-type="pmid">15509502</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asakura</surname><given-names>A</given-names></name><name><surname>Komaki</surname><given-names>M</given-names></name><name><surname>Rudnicki</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation</article-title><source>Differentiation; Research in Biological Diversity</source><volume>68</volume><fpage>245</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1046/j.1432-0436.2001.680412.x</pub-id><pub-id pub-id-type="pmid">11776477</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asakura</surname><given-names>A</given-names></name><name><surname>Seale</surname><given-names>P</given-names></name><name><surname>Girgis-Gabardo</surname><given-names>A</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Myogenic specification of side population cells in skeletal muscle</article-title><source>The Journal of Cell Biology</source><volume>159</volume><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1083/jcb.200202092</pub-id><pub-id pub-id-type="pmid">12379804</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>DG</given-names></name><name><surname>Kim</surname><given-names>TD</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Yoon</surname><given-names>WH</given-names></name><name><surname>Chae</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis</article-title><source>Clinical Cancer Research</source><volume>11</volume><fpage>2651</fpage><lpage>2661</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-1564</pub-id><pub-id pub-id-type="pmid">15814646</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakay</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Melcon</surname><given-names>G</given-names></name><name><surname>Schiltz</surname><given-names>L</given-names></name><name><surname>Xuan</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Sartorelli</surname><given-names>V</given-names></name><name><surname>Seo</surname><given-names>J</given-names></name><name><surname>Pegoraro</surname><given-names>E</given-names></name><name><surname>Angelini</surname><given-names>C</given-names></name><name><surname>Shneiderman</surname><given-names>B</given-names></name><name><surname>Escolar</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Winokur</surname><given-names>ST</given-names></name><name><surname>Pachman</surname><given-names>LM</given-names></name><name><surname>Fan</surname><given-names>C</given-names></name><name><surname>Mandler</surname><given-names>R</given-names></name><name><surname>Nevo</surname><given-names>Y</given-names></name><name><surname>Gordon</surname><given-names>E</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hoffman</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration</article-title><source>Brain</source><volume>129</volume><fpage>996</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.1093/brain/awl023</pub-id><pub-id pub-id-type="pmid">16478798</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boldrin</surname><given-names>L</given-names></name><name><surname>Zammit</surname><given-names>PS</given-names></name><name><surname>Morgan</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Satellite cells from dystrophic muscle retain regenerative capacity</article-title><source>Stem Cell Research</source><volume>14</volume><fpage>20</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.scr.2014.10.007</pub-id><pub-id pub-id-type="pmid">25460248</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosco</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Gabriëls</surname><given-names>S</given-names></name><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Miller</surname><given-names>BK</given-names></name><name><surname>Gu</surname><given-names>S</given-names></name><name><surname>Lundberg</surname><given-names>DM</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Brown</surname><given-names>E</given-names></name><name><surname>Josiah</surname><given-names>S</given-names></name><name><surname>Meiyappan</surname><given-names>M</given-names></name><name><surname>Traylor</surname><given-names>MJ</given-names></name><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name><name><surname>De Jonge</surname><given-names>N</given-names></name><name><surname>Blanchetot</surname><given-names>C</given-names></name><name><surname>de Haard</surname><given-names>H</given-names></name><name><surname>Duffy</surname><given-names>HS</given-names></name><name><surname>Keefe</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy</article-title><source>Molecular Therapy. Methods &amp; Clinical Development</source><volume>21</volume><fpage>369</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.omtm.2021.03.013</pub-id><pub-id pub-id-type="pmid">33898634</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchentouf</surname><given-names>M</given-names></name><name><surname>Benabdallah</surname><given-names>BF</given-names></name><name><surname>Bigey</surname><given-names>P</given-names></name><name><surname>Yau</surname><given-names>TM</given-names></name><name><surname>Scherman</surname><given-names>D</given-names></name><name><surname>Tremblay</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles</article-title><source>Gene Therapy</source><volume>15</volume><fpage>404</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1038/sj.gt.3303059</pub-id><pub-id pub-id-type="pmid">18079754</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryan</surname><given-names>BA</given-names></name><name><surname>Walshe</surname><given-names>TE</given-names></name><name><surname>Mitchell</surname><given-names>DC</given-names></name><name><surname>Havumaki</surname><given-names>JS</given-names></name><name><surname>Saint-Geniez</surname><given-names>M</given-names></name><name><surname>Maharaj</surname><given-names>AS</given-names></name><name><surname>Maldonado</surname><given-names>AE</given-names></name><name><surname>D’Amore</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation</article-title><source>Molecular Biology of the Cell</source><volume>19</volume><fpage>994</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1091/mbc.e07-09-0856</pub-id><pub-id pub-id-type="pmid">18094043</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>VM</given-names></name><name><surname>Miller</surname><given-names>DR</given-names></name><name><surname>Armstrong</surname><given-names>D</given-names></name><name><surname>Caskey</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice</article-title><source>PNAS</source><volume>86</volume><fpage>1292</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1073/pnas.86.4.1292</pub-id><pub-id pub-id-type="pmid">2919177</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charville</surname><given-names>GW</given-names></name><name><surname>Cheung</surname><given-names>TH</given-names></name><name><surname>Yoo</surname><given-names>B</given-names></name><name><surname>Santos</surname><given-names>PJ</given-names></name><name><surname>Lee</surname><given-names>GK</given-names></name><name><surname>Shrager</surname><given-names>JB</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ex vivo expansion and in vivo self-renewal of human muscle stem cells</article-title><source>Stem Cell Reports</source><volume>5</volume><fpage>621</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2015.08.004</pub-id><pub-id pub-id-type="pmid">26344908</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Borup</surname><given-names>R</given-names></name><name><surname>Hoffman</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology</article-title><source>The Journal of Cell Biology</source><volume>151</volume><fpage>1321</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.1083/jcb.151.6.1321</pub-id><pub-id pub-id-type="pmid">11121445</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>YX</given-names></name><name><surname>Ritso</surname><given-names>M</given-names></name><name><surname>Perkins</surname><given-names>TJ</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>KDR Signaling in Muscle Stem Cells Promotes Asymmetric Division and Progenitor Generation for Efficient Regeneration</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.06.27.497734</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chestnut</surname><given-names>B</given-names></name><name><surname>Casie Chetty</surname><given-names>S</given-names></name><name><surname>Koenig</surname><given-names>AL</given-names></name><name><surname>Sumanas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptomic analysis identifies the conversion of zebrafish Etv2-deficient vascular progenitors into skeletal muscle</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>2796</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16515-y</pub-id><pub-id pub-id-type="pmid">32493965</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christov</surname><given-names>C</given-names></name><name><surname>Chrétien</surname><given-names>F</given-names></name><name><surname>Abou-Khalil</surname><given-names>R</given-names></name><name><surname>Bassez</surname><given-names>G</given-names></name><name><surname>Vallet</surname><given-names>G</given-names></name><name><surname>Authier</surname><given-names>F-J</given-names></name><name><surname>Bassaglia</surname><given-names>Y</given-names></name><name><surname>Shinin</surname><given-names>V</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name><name><surname>Chazaud</surname><given-names>B</given-names></name><name><surname>Gherardi</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Muscle satellite cells and endothelial cells: close neighbors and privileged partners</article-title><source>Molecular Biology of the Cell</source><volume>18</volume><fpage>1397</fpage><lpage>1409</lpage><pub-id pub-id-type="doi">10.1091/mbc.e06-08-0693</pub-id><pub-id pub-id-type="pmid">17287398</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Angelis</surname><given-names>L</given-names></name><name><surname>Berghella</surname><given-names>L</given-names></name><name><surname>Coletta</surname><given-names>M</given-names></name><name><surname>Lattanzi</surname><given-names>L</given-names></name><name><surname>Zanchi</surname><given-names>M</given-names></name><name><surname>Cusella-De Angelis</surname><given-names>MG</given-names></name><name><surname>Ponzetto</surname><given-names>C</given-names></name><name><surname>Cossu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration</article-title><source>The Journal of Cell Biology</source><volume>147</volume><fpage>869</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1083/jcb.147.4.869</pub-id><pub-id pub-id-type="pmid">10562287</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delavar</surname><given-names>H</given-names></name><name><surname>Nogueira</surname><given-names>L</given-names></name><name><surname>Wagner</surname><given-names>PD</given-names></name><name><surname>Hogan</surname><given-names>MC</given-names></name><name><surname>Metzger</surname><given-names>D</given-names></name><name><surname>Breen</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Skeletal myofiber VEGF is essential for the exercise training response in adult mice</article-title><source>American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</source><volume>306</volume><fpage>R586</fpage><lpage>R595</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00522.2013</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Micheli</surname><given-names>AJ</given-names></name><name><surname>Laurilliard</surname><given-names>EJ</given-names></name><name><surname>Heinke</surname><given-names>CL</given-names></name><name><surname>Ravichandran</surname><given-names>H</given-names></name><name><surname>Fraczek</surname><given-names>P</given-names></name><name><surname>Soueid-Baumgarten</surname><given-names>S</given-names></name><name><surname>De Vlaminck</surname><given-names>I</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Cosgrove</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell analysis of the muscle stem cell hierarchy identifies heterotypic communication signals involved in skeletal muscle regeneration</article-title><source>Cell Reports</source><volume>30</volume><fpage>3583</fpage><lpage>3595</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.02.067</pub-id><pub-id pub-id-type="pmid">32160558</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desrochers</surname><given-names>LM</given-names></name><name><surname>Antonyak</surname><given-names>MA</given-names></name><name><surname>Cerione</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Extracellular vesicles: Satellites of information transfer in cancer and stem cell biology</article-title><source>Developmental Cell</source><volume>37</volume><fpage>301</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2016.04.019</pub-id><pub-id pub-id-type="pmid">27219060</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domigan</surname><given-names>CK</given-names></name><name><surname>Warren</surname><given-names>CM</given-names></name><name><surname>Antanesian</surname><given-names>V</given-names></name><name><surname>Happel</surname><given-names>K</given-names></name><name><surname>Ziyad</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Krall</surname><given-names>A</given-names></name><name><surname>Duan</surname><given-names>L</given-names></name><name><surname>Torres-Collado</surname><given-names>AX</given-names></name><name><surname>Castellani</surname><given-names>LW</given-names></name><name><surname>Elashoff</surname><given-names>D</given-names></name><name><surname>Christofk</surname><given-names>HR</given-names></name><name><surname>van der Bliek</surname><given-names>AM</given-names></name><name><surname>Potente</surname><given-names>M</given-names></name><name><surname>Iruela-Arispe</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy</article-title><source>Journal of Cell Science</source><volume>128</volume><fpage>2236</fpage><lpage>2248</lpage><pub-id pub-id-type="doi">10.1242/jcs.163774</pub-id><pub-id pub-id-type="pmid">25956888</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>CJ</given-names></name><name><surname>Hatley</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Case of mistaken identity: Rhabdomyosarcoma development from endothelial progenitor cells</article-title><source>Molecular &amp; Cellular Oncology</source><volume>5</volume><elocation-id>e1448246</elocation-id><pub-id pub-id-type="doi">10.1080/23723556.2018.1448246</pub-id><pub-id pub-id-type="pmid">30250910</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichmann</surname><given-names>A</given-names></name><name><surname>Marcelle</surname><given-names>C</given-names></name><name><surname>Bréant</surname><given-names>C</given-names></name><name><surname>Le Douarin</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development</article-title><source>Mechanisms of Development</source><volume>42</volume><fpage>33</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/0925-4773(93)90096-g</pub-id><pub-id pub-id-type="pmid">8396413</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ema</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors</article-title><source>Blood</source><volume>107</volume><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-05-1970</pub-id><pub-id pub-id-type="pmid">16166582</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esner</surname><given-names>M</given-names></name><name><surname>Meilhac</surname><given-names>SM</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Nicolas</surname><given-names>JF</given-names></name><name><surname>Cossu</surname><given-names>G</given-names></name><name><surname>Buckingham</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Smooth muscle of the dorsal aorta shares a common clonal origin with skeletal muscle of the myotome</article-title><source>Development</source><volume>133</volume><fpage>737</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1242/dev.02226</pub-id><pub-id pub-id-type="pmid">16436625</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukada</surname><given-names>S</given-names></name><name><surname>Uezumi</surname><given-names>A</given-names></name><name><surname>Ikemoto</surname><given-names>M</given-names></name><name><surname>Masuda</surname><given-names>S</given-names></name><name><surname>Segawa</surname><given-names>M</given-names></name><name><surname>Tanimura</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Miyagoe-Suzuki</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular signature of quiescent satellite cells in adult skeletal muscle</article-title><source>Stem Cells</source><volume>25</volume><fpage>2448</fpage><lpage>2459</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2007-0019</pub-id><pub-id pub-id-type="pmid">17600112</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gay</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>MR</given-names></name><name><surname>Ventura</surname><given-names>PB</given-names></name><name><surname>Devasthali</surname><given-names>V</given-names></name><name><surname>Vue</surname><given-names>Z</given-names></name><name><surname>Thompson</surname><given-names>HL</given-names></name><name><surname>Temple</surname><given-names>S</given-names></name><name><surname>Zong</surname><given-names>H</given-names></name><name><surname>Cleary</surname><given-names>MD</given-names></name><name><surname>Stankunas</surname><given-names>K</given-names></name><name><surname>Doe</surname><given-names>CQ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mouse TU tagging: a chemical/genetic intersectional method for purifying cell type-specific nascent RNA</article-title><source>Genes &amp; Development</source><volume>27</volume><fpage>98</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1101/gad.205278.112</pub-id><pub-id pub-id-type="pmid">23307870</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>HP</given-names></name><name><surname>McMurtrey</surname><given-names>A</given-names></name><name><surname>Kowalski</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Keyt</surname><given-names>BA</given-names></name><name><surname>Dixit</surname><given-names>V</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation</article-title><source>The Journal of Biological Chemistry</source><volume>273</volume><fpage>30336</fpage><lpage>30343</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.46.30336</pub-id><pub-id pub-id-type="pmid">9804796</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>HP</given-names></name><name><surname>Hillan</surname><given-names>KJ</given-names></name><name><surname>Ryan</surname><given-names>AM</given-names></name><name><surname>Kowalski</surname><given-names>J</given-names></name><name><surname>Keller</surname><given-names>GA</given-names></name><name><surname>Rangell</surname><given-names>L</given-names></name><name><surname>Wright</surname><given-names>BD</given-names></name><name><surname>Radtke</surname><given-names>F</given-names></name><name><surname>Aguet</surname><given-names>M</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>VEGF is required for growth and survival in neonatal mice</article-title><source>Development</source><volume>126</volume><fpage>1149</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1242/dev.126.6.1149</pub-id><pub-id pub-id-type="pmid">10021335</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germani</surname><given-names>A</given-names></name><name><surname>Di Carlo</surname><given-names>A</given-names></name><name><surname>Mangoni</surname><given-names>A</given-names></name><name><surname>Straino</surname><given-names>S</given-names></name><name><surname>Giacinti</surname><given-names>C</given-names></name><name><surname>Turrini</surname><given-names>P</given-names></name><name><surname>Biglioli</surname><given-names>P</given-names></name><name><surname>Capogrossi</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Vascular endothelial growth factor modulates skeletal myoblast function</article-title><source>The American Journal of Pathology</source><volume>163</volume><fpage>1417</fpage><lpage>1428</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)63499-2</pub-id><pub-id pub-id-type="pmid">14507649</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giordani</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>GJ</given-names></name><name><surname>Negroni</surname><given-names>E</given-names></name><name><surname>Sakai</surname><given-names>H</given-names></name><name><surname>Law</surname><given-names>JYC</given-names></name><name><surname>Siu</surname><given-names>MM</given-names></name><name><surname>Wan</surname><given-names>R</given-names></name><name><surname>Corneau</surname><given-names>A</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name><name><surname>Cheung</surname><given-names>TH</given-names></name><name><surname>Le Grand</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High-dimensional single-cell cartography reveals novel skeletal muscle-resident cell populations</article-title><source>Molecular Cell</source><volume>74</volume><fpage>609</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.02.026</pub-id><pub-id pub-id-type="pmid">30922843</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goel</surname><given-names>AJ</given-names></name><name><surname>Rieder</surname><given-names>MK</given-names></name><name><surname>Arnold</surname><given-names>HH</given-names></name><name><surname>Radice</surname><given-names>GL</given-names></name><name><surname>Krauss</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Niche cadherins control the quiescence-to-activation transition in muscle stem cells</article-title><source>Cell Reports</source><volume>21</volume><fpage>2236</fpage><lpage>2250</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.102</pub-id><pub-id pub-id-type="pmid">29166613</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groppa</surname><given-names>E</given-names></name><name><surname>Martini</surname><given-names>P</given-names></name><name><surname>Derakhshan</surname><given-names>N</given-names></name><name><surname>Theret</surname><given-names>M</given-names></name><name><surname>Ritso</surname><given-names>M</given-names></name><name><surname>Tung</surname><given-names>LW</given-names></name><name><surname>Wang</surname><given-names>YX</given-names></name><name><surname>Soliman</surname><given-names>H</given-names></name><name><surname>Hamer</surname><given-names>MS</given-names></name><name><surname>Stankiewicz</surname><given-names>L</given-names></name><name><surname>Eisner</surname><given-names>C</given-names></name><name><surname>Erwan</surname><given-names>LN</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Yi</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>JH</given-names></name><name><surname>Kong</surname><given-names>S</given-names></name><name><surname>Weng</surname><given-names>C</given-names></name><name><surname>Adams</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>A</given-names></name><name><surname>Blau</surname><given-names>HM</given-names></name><name><surname>Romualdi</surname><given-names>C</given-names></name><name><surname>Rossi</surname><given-names>FMV</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Spatial compartmentalization of signaling imparts source-specific functions on secreted factors</article-title><source>Cell Reports</source><volume>42</volume><elocation-id>112051</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112051</pub-id><pub-id pub-id-type="pmid">36729831</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>D</given-names></name><name><surname>Besnard</surname><given-names>A</given-names></name><name><surname>Latil</surname><given-names>M</given-names></name><name><surname>Jouvion</surname><given-names>G</given-names></name><name><surname>Briand</surname><given-names>D</given-names></name><name><surname>Thépenier</surname><given-names>C</given-names></name><name><surname>Pascal</surname><given-names>Q</given-names></name><name><surname>Guguin</surname><given-names>A</given-names></name><name><surname>Gayraud-Morel</surname><given-names>B</given-names></name><name><surname>Cavaillon</surname><given-names>JM</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name><name><surname>Rocheteau</surname><given-names>P</given-names></name><name><surname>Chrétien</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Comparative study of injury models for studying muscle regeneration in mice</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0147198</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0147198</pub-id><pub-id pub-id-type="pmid">26807982</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>H</given-names></name><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Tastad</surname><given-names>C</given-names></name><name><surname>Asakura</surname><given-names>Y</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3</article-title><source>The Journal of Cell Biology</source><volume>191</volume><fpage>347</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1083/jcb.201006025</pub-id><pub-id pub-id-type="pmid">20956382</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>VC</given-names></name><name><surname>Duan</surname><given-names>LJ</given-names></name><name><surname>Cronin</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>BT</given-names></name><name><surname>Fong</surname><given-names>GH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice</article-title><source>Circulation</source><volume>126</volume><fpage>741</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.091603</pub-id><pub-id pub-id-type="pmid">22753193</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Schulz</surname><given-names>TJ</given-names></name><name><surname>Beauvais</surname><given-names>A</given-names></name><name><surname>Tseng</surname><given-names>YH</given-names></name><name><surname>Gussoni</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intramuscular adipogenesis is inhibited by myo-endothelial progenitors with functioning Bmpr1a signalling</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>4063</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms5063</pub-id><pub-id pub-id-type="pmid">24898859</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutcheson</surname><given-names>DA</given-names></name><name><surname>Kardon</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genetic manipulations reveal dynamic cell and gene functions: Cre-ating a new view of myogenesis</article-title><source>Cell Cycle</source><volume>8</volume><fpage>3675</fpage><lpage>3678</lpage><pub-id pub-id-type="doi">10.4161/cc.8.22.9992</pub-id><pub-id pub-id-type="pmid">19844163</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kann</surname><given-names>AP</given-names></name><name><surname>Krauss</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multiplexed RNAscope and immunofluorescence on whole-mount skeletal myofibers and their associated stem cells</article-title><source>Development</source><volume>146</volume><elocation-id>dev179259</elocation-id><pub-id pub-id-type="doi">10.1242/dev.179259</pub-id><pub-id pub-id-type="pmid">31519691</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kardon</surname><given-names>G</given-names></name><name><surname>Campbell</surname><given-names>JK</given-names></name><name><surname>Tabin</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Local extrinsic signals determine muscle and endothelial cell fate and patterning in the vertebrate limb</article-title><source>Developmental Cell</source><volume>3</volume><fpage>533</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1016/s1534-5807(02)00291-5</pub-id><pub-id pub-id-type="pmid">12408805</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keifer</surname><given-names>OP</given-names><suffix>Jr</suffix></name><name><surname>O’Connor</surname><given-names>DM</given-names></name><name><surname>Boulis</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gene and protein therapies utilizing VEGF for ALS</article-title><source>Pharmacology &amp; Therapeutics</source><volume>141</volume><fpage>261</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2013.10.009</pub-id><pub-id pub-id-type="pmid">24177067</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>Butler</surname><given-names>JM</given-names></name><name><surname>O’Donnell</surname><given-names>R</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>B-S</given-names></name><name><surname>Bonner</surname><given-names>B</given-names></name><name><surname>Chiu</surname><given-names>VK</given-names></name><name><surname>Nolan</surname><given-names>DJ</given-names></name><name><surname>Shido</surname><given-names>K</given-names></name><name><surname>Benjamin</surname><given-names>L</given-names></name><name><surname>Rafii</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells</article-title><source>Nature Cell Biology</source><volume>12</volume><fpage>1046</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.1038/ncb2108</pub-id><pub-id pub-id-type="pmid">20972423</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kodippili</surname><given-names>K</given-names></name><name><surname>Thorne</surname><given-names>PK</given-names></name><name><surname>Laughlin</surname><given-names>MH</given-names></name><name><surname>Duan</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Dystrophin deficiency impairs vascular structure and function in the canine model of Duchenne muscular dystrophy</article-title><source>The Journal of Pathology</source><volume>254</volume><fpage>589</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/path.5704</pub-id><pub-id pub-id-type="pmid">33999411</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagha</surname><given-names>M</given-names></name><name><surname>Brunelli</surname><given-names>S</given-names></name><name><surname>Messina</surname><given-names>G</given-names></name><name><surname>Cumano</surname><given-names>A</given-names></name><name><surname>Kume</surname><given-names>T</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Buckingham</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Pax3:Foxc2 reciprocal repression in the somite modulates muscular versus vascular cell fate choice in multipotent progenitors</article-title><source>Developmental Cell</source><volume>17</volume><fpage>892</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.10.021</pub-id><pub-id pub-id-type="pmid">20059958</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latroche</surname><given-names>C</given-names></name><name><surname>Matot</surname><given-names>B</given-names></name><name><surname>Martins-Bach</surname><given-names>A</given-names></name><name><surname>Briand</surname><given-names>D</given-names></name><name><surname>Chazaud</surname><given-names>B</given-names></name><name><surname>Wary</surname><given-names>C</given-names></name><name><surname>Carlier</surname><given-names>PG</given-names></name><name><surname>Chrétien</surname><given-names>F</given-names></name><name><surname>Jouvion</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Structural and functional alterations of skeletal muscle microvasculature in dystrophin-deficient mdx mice</article-title><source>The American Journal of Pathology</source><volume>185</volume><fpage>2482</fpage><lpage>2494</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2015.05.009</pub-id><pub-id pub-id-type="pmid">26193666</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latroche</surname><given-names>C</given-names></name><name><surname>Weiss-Gayet</surname><given-names>M</given-names></name><name><surname>Muller</surname><given-names>L</given-names></name><name><surname>Gitiaux</surname><given-names>C</given-names></name><name><surname>Leblanc</surname><given-names>P</given-names></name><name><surname>Liot</surname><given-names>S</given-names></name><name><surname>Ben-Larbi</surname><given-names>S</given-names></name><name><surname>Abou-Khalil</surname><given-names>R</given-names></name><name><surname>Verger</surname><given-names>N</given-names></name><name><surname>Bardot</surname><given-names>P</given-names></name><name><surname>Magnan</surname><given-names>M</given-names></name><name><surname>Chrétien</surname><given-names>F</given-names></name><name><surname>Mounier</surname><given-names>R</given-names></name><name><surname>Germain</surname><given-names>S</given-names></name><name><surname>Chazaud</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Coupling between myogenesis and angiogenesis during skeletal muscle regeneration is stimulated by restorative macrophages</article-title><source>Stem Cell Reports</source><volume>9</volume><fpage>2018</fpage><lpage>2033</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.10.027</pub-id><pub-id pub-id-type="pmid">29198825</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Grand</surname><given-names>F</given-names></name><name><surname>Auda-Boucher</surname><given-names>G</given-names></name><name><surname>Levitsky</surname><given-names>D</given-names></name><name><surname>Rouaud</surname><given-names>T</given-names></name><name><surname>Fontaine-Pérus</surname><given-names>J</given-names></name><name><surname>Gardahaut</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Endothelial cells within embryonic skeletal muscles: a potential source of myogenic progenitors</article-title><source>Experimental Cell Research</source><volume>301</volume><fpage>232</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2004.07.028</pub-id><pub-id pub-id-type="pmid">15530859</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>TT</given-names></name><name><surname>Barber</surname><given-names>CL</given-names></name><name><surname>Jordan</surname><given-names>MC</given-names></name><name><surname>Murdock</surname><given-names>J</given-names></name><name><surname>Desai</surname><given-names>S</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Roos</surname><given-names>KP</given-names></name><name><surname>Iruela-Arispe</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Autocrine VEGF signaling is required for vascular homeostasis</article-title><source>Cell</source><volume>130</volume><fpage>691</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.06.054</pub-id><pub-id pub-id-type="pmid">17719546</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Nagai</surname><given-names>N</given-names></name><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Scotney</surname><given-names>P</given-names></name><name><surname>Lennartsson</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>C</given-names></name><name><surname>Hua</surname><given-names>J</given-names></name><name><surname>Matsuo</surname><given-names>O</given-names></name><name><surname>Fong</surname><given-names>GH</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Becker</surname><given-names>KG</given-names></name><name><surname>Nash</surname><given-names>A</given-names></name><name><surname>Heldin</surname><given-names>CH</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats</article-title><source>The Journal of Clinical Investigation</source><volume>118</volume><fpage>913</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1172/JCI33673</pub-id><pub-id pub-id-type="pmid">18259607</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linderman</surname><given-names>GC</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Roulis</surname><given-names>M</given-names></name><name><surname>Bielecki</surname><given-names>P</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Nadler</surname><given-names>B</given-names></name><name><surname>Kluger</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Zero-preserving imputation of single-cell RNA-seq data</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>192</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-27729-z</pub-id><pub-id pub-id-type="pmid">35017482</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Berendsen</surname><given-names>AD</given-names></name><name><surname>Jia</surname><given-names>S</given-names></name><name><surname>Lotinun</surname><given-names>S</given-names></name><name><surname>Baron</surname><given-names>R</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name><name><surname>Olsen</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation</article-title><source>Journal of Clinical Investigation</source><volume>122</volume><fpage>3101</fpage><lpage>3113</lpage><pub-id pub-id-type="doi">10.1172/JCI61209</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Cheung</surname><given-names>TH</given-names></name><name><surname>Charville</surname><given-names>GW</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Isolation of skeletal muscle stem cells by fluorescence-activated cell sorting</article-title><source>Nature Protocols</source><volume>10</volume><fpage>1612</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.110</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loiben</surname><given-names>AM</given-names></name><name><surname>Soueid-Baumgarten</surname><given-names>S</given-names></name><name><surname>Kopyto</surname><given-names>RF</given-names></name><name><surname>Bhattacharya</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>JC</given-names></name><name><surname>Cosgrove</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Data-modeling identifies conflicting signaling axes governing myoblast proliferation and differentiation responses to diverse ligand stimuli</article-title><source>Cellular and Molecular Bioengineering</source><volume>10</volume><fpage>433</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1007/s12195-017-0508-5</pub-id><pub-id pub-id-type="pmid">31719871</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mac Gabhann</surname><given-names>F</given-names></name><name><surname>Qutub</surname><given-names>AA</given-names></name><name><surname>Annex</surname><given-names>BH</given-names></name><name><surname>Popel</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Systems biology of pro-angiogenic therapies targeting the VEGF system</article-title><source>Wiley Interdisciplinary Reviews. Systems Biology and Medicine</source><volume>2</volume><fpage>694</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1002/wsbm.92</pub-id><pub-id pub-id-type="pmid">20890966</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname><given-names>L</given-names></name><name><surname>Zwingman</surname><given-names>TA</given-names></name><name><surname>Sunkin</surname><given-names>SM</given-names></name><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Zariwala</surname><given-names>HA</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Ng</surname><given-names>LL</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name><name><surname>Lein</surname><given-names>ES</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput Cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayeuf-Louchart</surname><given-names>A</given-names></name><name><surname>Lagha</surname><given-names>M</given-names></name><name><surname>Danckaert</surname><given-names>A</given-names></name><name><surname>Rocancourt</surname><given-names>D</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Vincent</surname><given-names>SD</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Notch regulation of myogenic versus endothelial fates of cells that migrate from the somite to the limb</article-title><source>PNAS</source><volume>111</volume><fpage>8844</fpage><lpage>8849</lpage><pub-id pub-id-type="doi">10.1073/pnas.1407606111</pub-id><pub-id pub-id-type="pmid">24927569</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayeuf-Louchart</surname><given-names>A</given-names></name><name><surname>Montarras</surname><given-names>D</given-names></name><name><surname>Bodin</surname><given-names>C</given-names></name><name><surname>Kume</surname><given-names>T</given-names></name><name><surname>Vincent</surname><given-names>SD</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Endothelial cell specification in the somite is compromised in Pax3-positive progenitors of Foxc1/2 conditional mutants, with loss of forelimb myogenesis</article-title><source>Development</source><volume>143</volume><fpage>872</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1242/dev.128017</pub-id><pub-id pub-id-type="pmid">26839363</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercatelli</surname><given-names>N</given-names></name><name><surname>Dimauro</surname><given-names>I</given-names></name><name><surname>Ciafré</surname><given-names>SA</given-names></name><name><surname>Farace</surname><given-names>MG</given-names></name><name><surname>Caporossi</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>AlphaB-crystallin is involved in oxidative stress protection determined by VEGF in skeletal myoblasts</article-title><source>Free Radical Biology &amp; Medicine</source><volume>49</volume><fpage>374</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.04.027</pub-id><pub-id pub-id-type="pmid">20441791</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>S</given-names></name><name><surname>Mazzeo</surname><given-names>A</given-names></name><name><surname>Bitto</surname><given-names>A</given-names></name><name><surname>Aguennouz</surname><given-names>M</given-names></name><name><surname>Migliorato</surname><given-names>A</given-names></name><name><surname>De Pasquale</surname><given-names>MG</given-names></name><name><surname>Minutoli</surname><given-names>L</given-names></name><name><surname>Altavilla</surname><given-names>D</given-names></name><name><surname>Zentilin</surname><given-names>L</given-names></name><name><surname>Giacca</surname><given-names>M</given-names></name><name><surname>Squadrito</surname><given-names>F</given-names></name><name><surname>Vita</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice</article-title><source>FASEB Journal</source><volume>21</volume><fpage>3737</fpage><lpage>3746</lpage><pub-id pub-id-type="doi">10.1096/fj.07-8459com</pub-id><pub-id pub-id-type="pmid">17575261</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minasi</surname><given-names>MG</given-names></name><name><surname>Riminucci</surname><given-names>M</given-names></name><name><surname>De Angelis</surname><given-names>L</given-names></name><name><surname>Borello</surname><given-names>U</given-names></name><name><surname>Berarducci</surname><given-names>B</given-names></name><name><surname>Innocenzi</surname><given-names>A</given-names></name><name><surname>Caprioli</surname><given-names>A</given-names></name><name><surname>Sirabella</surname><given-names>D</given-names></name><name><surname>Baiocchi</surname><given-names>M</given-names></name><name><surname>De Maria</surname><given-names>R</given-names></name><name><surname>Boratto</surname><given-names>R</given-names></name><name><surname>Jaffredo</surname><given-names>T</given-names></name><name><surname>Broccoli</surname><given-names>V</given-names></name><name><surname>Bianco</surname><given-names>P</given-names></name><name><surname>Cossu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues</article-title><source>Development</source><volume>129</volume><fpage>2773</fpage><lpage>2783</lpage><pub-id pub-id-type="doi">10.1242/dev.129.11.2773</pub-id><pub-id pub-id-type="pmid">12015303</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miquerol</surname><given-names>L</given-names></name><name><surname>Gertsenstein</surname><given-names>M</given-names></name><name><surname>Harpal</surname><given-names>K</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Multiple developmental roles of VEGF suggested by a LacZ-tagged allele</article-title><source>Developmental Biology</source><volume>212</volume><fpage>307</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1006/dbio.1999.9355</pub-id><pub-id pub-id-type="pmid">10433823</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motohashi</surname><given-names>N</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Muscle satellite cell heterogeneity and self-renewal</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>2</volume><elocation-id>1</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2014.00001</pub-id><pub-id pub-id-type="pmid">25364710</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motohashi</surname><given-names>N</given-names></name><name><surname>Asakura</surname><given-names>Y</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Isolation, culture, and transplantation of muscle satellite cells</article-title><source>Journal of Visualized Experiments</source><volume>50846</volume><elocation-id>50846</elocation-id><pub-id pub-id-type="doi">10.3791/50846</pub-id><pub-id pub-id-type="pmid">24747722</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motoike</surname><given-names>T</given-names></name><name><surname>Markham</surname><given-names>DW</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Sato</surname><given-names>TN</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Evidence for novel fate of Flk1+ progenitor: contribution to muscle lineage</article-title><source>Genesis</source><volume>35</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1002/gene.10175</pub-id><pub-id pub-id-type="pmid">12640619</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murach</surname><given-names>KA</given-names></name><name><surname>Vechetti</surname><given-names>IJ</given-names></name><name><surname>Van Pelt</surname><given-names>DW</given-names></name><name><surname>Crow</surname><given-names>SE</given-names></name><name><surname>Dungan</surname><given-names>CM</given-names></name><name><surname>Figueiredo</surname><given-names>VC</given-names></name><name><surname>Kosmac</surname><given-names>K</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Richards</surname><given-names>CI</given-names></name><name><surname>Fry</surname><given-names>CS</given-names></name><name><surname>McCarthy</surname><given-names>JJ</given-names></name><name><surname>Peterson</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Fusion-independent satellite cell communication to muscle fibers during load-induced hypertrophy</article-title><source>Function</source><volume>1</volume><elocation-id>zqaa009</elocation-id><pub-id pub-id-type="doi">10.1093/function/zqaa009</pub-id><pub-id pub-id-type="pmid">32864621</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>MM</given-names></name><name><surname>Lawson</surname><given-names>JA</given-names></name><name><surname>Mathew</surname><given-names>SJ</given-names></name><name><surname>Hutcheson</surname><given-names>DA</given-names></name><name><surname>Kardon</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration</article-title><source>Journal of Cell Science</source><volume>124</volume><elocation-id>e1</elocation-id><pub-id pub-id-type="doi">10.1242/jcs098228</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noren</surname><given-names>DP</given-names></name><name><surname>Chou</surname><given-names>WH</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Qutub</surname><given-names>AA</given-names></name><name><surname>Warmflash</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>DS</given-names></name><name><surname>Popel</surname><given-names>AS</given-names></name><name><surname>Levchenko</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Endothelial cells decode VEGF-mediated Ca2+ signaling patterns to produce distinct functional responses</article-title><source>Science Signaling</source><volume>9</volume><elocation-id>ra20</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aad3188</pub-id><pub-id pub-id-type="pmid">26905425</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okabe</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Kurihara</surname><given-names>T</given-names></name><name><surname>Tai-Nagara</surname><given-names>I</given-names></name><name><surname>Miyamoto</surname><given-names>T</given-names></name><name><surname>Mukouyama</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>TN</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name><name><surname>Ema</surname><given-names>M</given-names></name><name><surname>Kubota</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neurons limit angiogenesis by titrating VEGF in retina</article-title><source>Cell</source><volume>159</volume><fpage>584</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.09.025</pub-id><pub-id pub-id-type="pmid">25417109</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olfert</surname><given-names>IM</given-names></name><name><surname>Howlett</surname><given-names>RA</given-names></name><name><surname>Tang</surname><given-names>K</given-names></name><name><surname>Dalton</surname><given-names>ND</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Peterson</surname><given-names>KL</given-names></name><name><surname>Wagner</surname><given-names>PD</given-names></name><name><surname>Breen</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice</article-title><source>The Journal of Physiology</source><volume>587</volume><fpage>1755</fpage><lpage>1767</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2008.164384</pub-id><pub-id pub-id-type="pmid">19237429</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallafacchina</surname><given-names>G</given-names></name><name><surname>François</surname><given-names>S</given-names></name><name><surname>Regnault</surname><given-names>B</given-names></name><name><surname>Czarny</surname><given-names>B</given-names></name><name><surname>Dive</surname><given-names>V</given-names></name><name><surname>Cumano</surname><given-names>A</given-names></name><name><surname>Montarras</surname><given-names>D</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>An adult tissue-specific stem cell in its niche: a gene profiling analysis of in vivo quiescent and activated muscle satellite cells</article-title><source>Stem Cell Research</source><volume>4</volume><fpage>77</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.scr.2009.10.003</pub-id><pub-id pub-id-type="pmid">19962952</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertea</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Pertea</surname><given-names>GM</given-names></name><name><surname>Leek</surname><given-names>JT</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown</article-title><source>Nature Protocols</source><volume>11</volume><fpage>1650</fpage><lpage>1667</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.095</pub-id><pub-id pub-id-type="pmid">27560171</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podkalicka</surname><given-names>P</given-names></name><name><surname>Mucha</surname><given-names>O</given-names></name><name><surname>Kaziród</surname><given-names>K</given-names></name><name><surname>Bronisz-Budzyńska</surname><given-names>I</given-names></name><name><surname>Ostrowska-Paton</surname><given-names>S</given-names></name><name><surname>Tomczyk</surname><given-names>M</given-names></name><name><surname>Andrysiak</surname><given-names>K</given-names></name><name><surname>Stępniewski</surname><given-names>J</given-names></name><name><surname>Dulak</surname><given-names>J</given-names></name><name><surname>Łoboda</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Age-dependent dysregulation of muscle vasculature and blood flow recovery after hindlimb ischemia in the <italic>mdx</italic> model of duchenne muscular dystrophy</article-title><source>Biomedicines</source><volume>9</volume><elocation-id>481</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines9050481</pub-id><pub-id pub-id-type="pmid">33925757</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poesen</surname><given-names>K</given-names></name><name><surname>Lambrechts</surname><given-names>D</given-names></name><name><surname>Van Damme</surname><given-names>P</given-names></name><name><surname>Dhondt</surname><given-names>J</given-names></name><name><surname>Bender</surname><given-names>F</given-names></name><name><surname>Frank</surname><given-names>N</given-names></name><name><surname>Bogaert</surname><given-names>E</given-names></name><name><surname>Claes</surname><given-names>B</given-names></name><name><surname>Heylen</surname><given-names>L</given-names></name><name><surname>Verheyen</surname><given-names>A</given-names></name><name><surname>Raes</surname><given-names>K</given-names></name><name><surname>Tjwa</surname><given-names>M</given-names></name><name><surname>Eriksson</surname><given-names>U</given-names></name><name><surname>Shibuya</surname><given-names>M</given-names></name><name><surname>Nuydens</surname><given-names>R</given-names></name><name><surname>Van Den Bosch</surname><given-names>L</given-names></name><name><surname>Meert</surname><given-names>T</given-names></name><name><surname>D’Hooge</surname><given-names>R</given-names></name><name><surname>Sendtner</surname><given-names>M</given-names></name><name><surname>Robberecht</surname><given-names>W</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>10451</fpage><lpage>10459</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1092-08.2008</pub-id><pub-id pub-id-type="pmid">18923022</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roobrouck</surname><given-names>VD</given-names></name><name><surname>Clavel</surname><given-names>C</given-names></name><name><surname>Jacobs</surname><given-names>SA</given-names></name><name><surname>Ulloa-Montoya</surname><given-names>F</given-names></name><name><surname>Crippa</surname><given-names>S</given-names></name><name><surname>Sohni</surname><given-names>A</given-names></name><name><surname>Roberts</surname><given-names>SJ</given-names></name><name><surname>Luyten</surname><given-names>FP</given-names></name><name><surname>Van Gool</surname><given-names>SW</given-names></name><name><surname>Sampaolesi</surname><given-names>M</given-names></name><name><surname>Delforge</surname><given-names>M</given-names></name><name><surname>Luttun</surname><given-names>A</given-names></name><name><surname>Verfaillie</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions</article-title><source>Stem Cells</source><volume>29</volume><fpage>871</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1002/stem.633</pub-id><pub-id pub-id-type="pmid">21433224</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="software"><person-group person-group-type="author"><collab>RStudio Team</collab></person-group><year iso-8601-date="2020">2020</year><data-title>Rstudio: integrated development for R</data-title><publisher-loc>Boston, MA</publisher-loc><publisher-name>RStudio, PBC</publisher-name><ext-link ext-link-type="uri" xlink:href="http://www.rstudio.com/pod">http://www.rstudio.com/pod</ext-link></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryall</surname><given-names>JG</given-names></name><name><surname>Dell’Orso</surname><given-names>S</given-names></name><name><surname>Derfoul</surname><given-names>A</given-names></name><name><surname>Juan</surname><given-names>A</given-names></name><name><surname>Zare</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Clermont</surname><given-names>D</given-names></name><name><surname>Koulnis</surname><given-names>M</given-names></name><name><surname>Gutierrez-Cruz</surname><given-names>G</given-names></name><name><surname>Fulco</surname><given-names>M</given-names></name><name><surname>Sartorelli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells</article-title><source>Cell Stem Cell</source><volume>16</volume><fpage>171</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.12.004</pub-id><pub-id pub-id-type="pmid">25600643</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname><given-names>H</given-names></name><name><surname>Okawa</surname><given-names>Y</given-names></name><name><surname>Inami</surname><given-names>Y</given-names></name><name><surname>Nishio</surname><given-names>N</given-names></name><name><surname>Isobe</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells</article-title><source>Stem Cells</source><volume>26</volume><fpage>1865</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2008-0173</pub-id><pub-id pub-id-type="pmid">18450822</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu-Motohashi</surname><given-names>Y</given-names></name><name><surname>Asakura</surname><given-names>Y</given-names></name><name><surname>Motohashi</surname><given-names>N</given-names></name><name><surname>Belur</surname><given-names>NR</given-names></name><name><surname>Baumrucker</surname><given-names>MG</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0120325</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0120325</pub-id><pub-id pub-id-type="pmid">25775477</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamaki</surname><given-names>T</given-names></name><name><surname>Akatsuka</surname><given-names>A</given-names></name><name><surname>Ando</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Matsuzawa</surname><given-names>H</given-names></name><name><surname>Hotta</surname><given-names>T</given-names></name><name><surname>Roy</surname><given-names>RR</given-names></name><name><surname>Edgerton</surname><given-names>VR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle</article-title><source>The Journal of Cell Biology</source><volume>157</volume><fpage>571</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1083/jcb.200112106</pub-id><pub-id pub-id-type="pmid">11994315</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>K</given-names></name><name><surname>Breen</surname><given-names>EC</given-names></name><name><surname>Gerber</surname><given-names>HP</given-names></name><name><surname>Ferrara</surname><given-names>NMA</given-names></name><name><surname>Wagner</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Capillary regression in vascular endothelial growth factor-deficient skeletal muscle</article-title><source>Physiological Genomics</source><volume>18</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1152/physiolgenomics.00023.2004</pub-id><pub-id pub-id-type="pmid">15084712</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torre</surname><given-names>E</given-names></name><name><surname>Dueck</surname><given-names>H</given-names></name><name><surname>Shaffer</surname><given-names>S</given-names></name><name><surname>Gospocic</surname><given-names>J</given-names></name><name><surname>Gupte</surname><given-names>R</given-names></name><name><surname>Bonasio</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Raj</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rare Cell Detection by Single-Cell RNA Sequencing as Guided by Single-Molecule RNA FISH</article-title><source>Cell Systems</source><volume>6</volume><fpage>171</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2018.01.014</pub-id><pub-id pub-id-type="pmid">29454938</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tozer</surname><given-names>S</given-names></name><name><surname>Bonnin</surname><given-names>M-A</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Di Savino</surname><given-names>S</given-names></name><name><surname>García-Villalba</surname><given-names>P</given-names></name><name><surname>Coumailleau</surname><given-names>P</given-names></name><name><surname>Duprez</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Involvement of vessels and PDGFB in muscle splitting during chick limb development</article-title><source>Development</source><volume>134</volume><fpage>2579</fpage><lpage>2591</lpage><pub-id pub-id-type="doi">10.1242/dev.02867</pub-id><pub-id pub-id-type="pmid">17553906</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>BS</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Pattison</surname><given-names>JS</given-names></name><name><surname>Gordon</surname><given-names>SE</given-names></name><name><surname>Granchelli</surname><given-names>JA</given-names></name><name><surname>Madsen</surname><given-names>RW</given-names></name><name><surname>Folk</surname><given-names>LC</given-names></name><name><surname>Hoffman</surname><given-names>EP</given-names></name><name><surname>Booth</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Regenerated mdx mouse skeletal muscle shows differential mRNA expression</article-title><source>Journal of Applied Physiology</source><volume>93</volume><fpage>537</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00202.2002</pub-id><pub-id pub-id-type="pmid">12133862</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turaç</surname><given-names>G</given-names></name><name><surname>Hindley</surname><given-names>CJ</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Davis</surname><given-names>JA</given-names></name><name><surname>Deleidi</surname><given-names>M</given-names></name><name><surname>Gasser</surname><given-names>T</given-names></name><name><surname>Karaöz</surname><given-names>E</given-names></name><name><surname>Pruszak</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Combined flow cytometric analysis of surface and intracellular antigens reveals surface molecule markers of human neuropoiesis</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e68519</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0068519</pub-id><pub-id pub-id-type="pmid">23826393</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Velthoven</surname><given-names>CTJ</given-names></name><name><surname>de Morree</surname><given-names>A</given-names></name><name><surname>Egner</surname><given-names>IM</given-names></name><name><surname>Brett</surname><given-names>JO</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptional profiling of quiescent muscle stem cells invivo</article-title><source>Cell Reports</source><volume>21</volume><fpage>1994</fpage><lpage>2004</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.037</pub-id><pub-id pub-id-type="pmid">29141228</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldman</surname><given-names>MB</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Gomez</surname><given-names>GA</given-names></name><name><surname>Lindgren</surname><given-names>AG</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>BL</given-names></name><name><surname>Kimelman</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transdifferentiation of fast skeletal muscle into functional endothelium in vivo by transcription factor Etv2</article-title><source>PLOS Biology</source><volume>11</volume><elocation-id>e1001590</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001590</pub-id><pub-id pub-id-type="pmid">23853546</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vempati</surname><given-names>P</given-names></name><name><surname>Popel</surname><given-names>AS</given-names></name><name><surname>Mac Gabhann</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning</article-title><source>Cytokine &amp; Growth Factor Reviews</source><volume>25</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2013.11.002</pub-id><pub-id pub-id-type="pmid">24332926</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Asakura</surname><given-names>Y</given-names></name><name><surname>Hirai</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Tastad</surname><given-names>C</given-names></name><name><surname>Fong</surname><given-names>GH</given-names></name><name><surname>Ema</surname><given-names>M</given-names></name><name><surname>Call</surname><given-names>JA</given-names></name><name><surname>Lowe</surname><given-names>DA</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice</article-title><source>Human Molecular Genetics</source><volume>19</volume><fpage>4145</fpage><lpage>4159</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq334</pub-id><pub-id pub-id-type="pmid">20705734</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Asakura</surname><given-names>Y</given-names></name><name><surname>Murakonda</surname><given-names>BSR</given-names></name><name><surname>Pengo</surname><given-names>T</given-names></name><name><surname>Latroche</surname><given-names>C</given-names></name><name><surname>Chazaud</surname><given-names>B</given-names></name><name><surname>McLoon</surname><given-names>LK</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Muscle Satellite Cell Cross-Talk with a Vascular Niche Maintains Quiescence via VEGF and Notch Signaling</article-title><source>Cell Stem Cell</source><volume>23</volume><fpage>530</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.09.007</pub-id><pub-id pub-id-type="pmid">30290177</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Shimizu-Motohashi</surname><given-names>Y</given-names></name><name><surname>Asakura</surname><given-names>Y</given-names></name><name><surname>Ennen</surname><given-names>JP</given-names></name><name><surname>Bosco</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Fong</surname><given-names>GH</given-names></name><name><surname>Josiah</surname><given-names>S</given-names></name><name><surname>Keefe</surname><given-names>D</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1008468</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008468</pub-id><pub-id pub-id-type="pmid">31877123</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>10Xcustomref</data-title><version designator="swh:1:rev:9a7cc8726686e1aed2d0fa5abd60a1a884463802">swh:1:rev:9a7cc8726686e1aed2d0fa5abd60a1a884463802</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:6723983bc03da139f5a3ff1094de9f35210e5d14;origin=https://github.com/verma014/10XCustomRef;visit=swh:1:snp:09c554a8975d34263a1ba160f5f50645d8ce8fea;anchor=swh:1:rev:9a7cc8726686e1aed2d0fa5abd60a1a884463802">https://archive.softwareheritage.org/swh:1:dir:6723983bc03da139f5a3ff1094de9f35210e5d14;origin=https://github.com/verma014/10XCustomRef;visit=swh:1:snp:09c554a8975d34263a1ba160f5f50645d8ce8fea;anchor=swh:1:rev:9a7cc8726686e1aed2d0fa5abd60a1a884463802</ext-link></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>NM</given-names></name><name><surname>Elvers</surname><given-names>I</given-names></name><name><surname>Alexander</surname><given-names>MS</given-names></name><name><surname>Moreira</surname><given-names>YB</given-names></name><name><surname>Eran</surname><given-names>A</given-names></name><name><surname>Gomes</surname><given-names>JP</given-names></name><name><surname>Marshall</surname><given-names>JL</given-names></name><name><surname>Karlsson</surname><given-names>EK</given-names></name><name><surname>Verjovski-Almeida</surname><given-names>S</given-names></name><name><surname>Lindblad-Toh</surname><given-names>K</given-names></name><name><surname>Kunkel</surname><given-names>LM</given-names></name><name><surname>Zatz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Jagged 1 rescues the duchenne muscular dystrophy phenotype</article-title><source>Cell</source><volume>163</volume><fpage>1204</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.10.049</pub-id><pub-id pub-id-type="pmid">26582133</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>PD</given-names></name><name><surname>Olfert</surname><given-names>IM</given-names></name><name><surname>Tang</surname><given-names>K</given-names></name><name><surname>Breen</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Muscle-targeted deletion of VEGF and exercise capacity in mice</article-title><source>Respiratory Physiology &amp; Neurobiology</source><volume>151</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.resp.2005.09.007</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Qaher</surname><given-names>M</given-names></name><name><surname>Horton</surname><given-names>HE</given-names></name><name><surname>Yue</surname><given-names>F</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name><name><surname>Kuang</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Loss of MyoD promotes fate transdifferentiation of myoblasts into brown adipocytes</article-title><source>EBioMedicine</source><volume>16</volume><fpage>212</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2017.01.015</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>C</given-names></name><name><surname>Chu</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Kuang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>You</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Combined gene therapy via VEGF and mini-dystrophin synergistically improves pathologies in temporalis muscle of dystrophin/utrophin double knockout mice</article-title><source>Human Molecular Genetics</source><volume>30</volume><fpage>1349</fpage><lpage>1359</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddab120</pub-id><pub-id pub-id-type="pmid">33987645</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Zu</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors</article-title><source>Biochemical and Biophysical Research Communications</source><volume>336</volume><fpage>287</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.08.066</pub-id><pub-id pub-id-type="pmid">16129416</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>W</given-names></name><name><surname>Veldman</surname><given-names>MB</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Engineering vascularized skeletal muscle tissue with transcriptional factor ETV2-induced autologous endothelial cells</article-title><source>Protein &amp; Cell</source><volume>10</volume><fpage>217</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1007/s13238-018-0542-7</pub-id><pub-id pub-id-type="pmid">29687363</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>MD</given-names></name><name><surname>Behjati</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data</article-title><source>GigaScience</source><volume>9</volume><elocation-id>giaa151</elocation-id><pub-id pub-id-type="doi">10.1093/gigascience/giaa151</pub-id><pub-id pub-id-type="pmid">33367645</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>L</given-names></name><name><surname>Wan</surname><given-names>R</given-names></name><name><surname>Luan</surname><given-names>S</given-names></name><name><surname>Zeng</surname><given-names>W</given-names></name><name><surname>Cheung</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dek modulates global intron retention during muscle stem cells quiescence exit</article-title><source>Developmental Cell</source><volume>53</volume><fpage>661</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.05.006</pub-id><pub-id pub-id-type="pmid">32502396</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>MJ</given-names></name><name><surname>Ntranos</surname><given-names>V</given-names></name><name><surname>Tse</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Determining sequencing depth in a single-cell RNA-seq experiment</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>774</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14482-y</pub-id><pub-id pub-id-type="pmid">32034137</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name><name><surname>Crisan</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Logar</surname><given-names>A</given-names></name><name><surname>Yap</surname><given-names>S</given-names></name><name><surname>Pollett</surname><given-names>JB</given-names></name><name><surname>Drowley</surname><given-names>L</given-names></name><name><surname>Cassino</surname><given-names>T</given-names></name><name><surname>Gharaibeh</surname><given-names>B</given-names></name><name><surname>Deasy</surname><given-names>BM</given-names></name><name><surname>Huard</surname><given-names>J</given-names></name><name><surname>Péault</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Prospective identification of myogenic endothelial cells in human skeletal muscle</article-title><source>Nature Biotechnology</source><volume>25</volume><fpage>1025</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1038/nbt1334</pub-id><pub-id pub-id-type="pmid">17767154</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Flt1LoxP/LoxP</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">JAX: 028098</td><td align="left" valign="bottom">Mouse line obtained from Guo-Hua Fong</td></tr><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">VEGFA+/Hyper</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">JAX: 027314</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Pax7CreERT2/+</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">JAX: 017763</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">mdx5cv</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">JAX: 002379</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Flk1GFP</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">JAX: 017006</td><td align="left" valign="bottom">Mouse line obtained from Masatsugu Ema</td></tr><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">R26RtdT</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">JAX: 007909</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">VEGFALoxP/LoxP</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Mouse line obtained from Napoleone Ferrara</td></tr><tr><td align="left" valign="bottom">Genetic reagent</td><td align="left" valign="bottom">Lentiviral pCCL-E4ORF1</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20972423/">20972423</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Viral vector production</td></tr><tr><td align="left" valign="bottom">Genetic reagent</td><td align="left" valign="bottom">Lentiviral pCCL-myrAkt1</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20972423/">20972423</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Viral vector production</td></tr><tr><td align="left" valign="bottom">Genetic reagent</td><td align="left" valign="bottom">pCMV-VSV-G</td><td align="left" valign="bottom">Addgene</td><td align="char" char="." valign="bottom">8454</td><td align="left" valign="bottom">Viral vector production</td></tr><tr><td align="left" valign="bottom">Genetic reagent</td><td align="left" valign="bottom">pRSV-Rev</td><td align="left" valign="bottom">Addgene</td><td align="char" char="." valign="bottom">12253</td><td align="left" valign="bottom">Viral vector production</td></tr><tr><td align="left" valign="bottom">Genetic reagent</td><td align="left" valign="bottom">pMDLg/pRRE</td><td align="left" valign="bottom">Addgene</td><td align="char" char="." valign="bottom">12251</td><td align="left" valign="bottom">Viral vector production</td></tr><tr><td align="left" valign="bottom">Genetic reagent</td><td align="left" valign="bottom">RNAscope Probe - Mm-Flt1 (C1)</td><td align="left" valign="bottom">ACDBio</td><td align="char" char="." valign="bottom">415541</td><td align="left" valign="bottom">RNAscope</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="char" char="." valign="bottom">293 FT</td><td align="left" valign="bottom">ThermoFisher Scoentific</td><td align="left" valign="bottom">R70007</td><td align="left" valign="bottom">Viral vector production</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C2C12</td><td align="left" valign="bottom">American Type Culture Collection (ATCC)</td><td align="left" valign="bottom">CRL-1772</td><td align="left" valign="bottom">MuSC line</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">bEnd.3</td><td align="left" valign="bottom">American Type Culture Collection (ATCC)</td><td align="left" valign="bottom">CRL-2299</td><td align="left" valign="bottom">EC line</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C166</td><td align="left" valign="bottom">American Type Culture Collection (ATCC)</td><td align="left" valign="bottom">CRL-2581</td><td align="left" valign="bottom">EC line</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD31-PE (Rat monoclonal)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">12-0311-82; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_465632">AB_465632</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD45-PE (Rat monoclonal)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">12-0451-81; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_465668">AB_465668</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Sca-1-PE (Rat monoclonal)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A18486; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535332">AB_2535332</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FLT1 (Mouse monoclonal)</td><td align="left" valign="bottom">R&amp;D systems</td><td align="left" valign="bottom">MAB4711; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2107038">AB_2107038</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FLT1-APC (Rat monoclonal)</td><td align="left" valign="bottom">R&amp;D systems</td><td align="left" valign="bottom">FAB4711A; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_622149">AB_622149</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FLK1 (Rat monoclonal)</td><td align="left" valign="bottom">BD Biosceinces</td><td align="left" valign="bottom">555307; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_395720">AB_395720</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FLK1-APC (Rat monoclonal)</td><td align="left" valign="bottom">BD Biosceinces</td><td align="left" valign="bottom">560070; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:C28AB_1645226">C28AB_1645226</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-VE-cadherin (Rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">555289; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2244723">AB_2244723</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NRP1 (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">3725; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2155231">AB_2155231</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NRP1-APC (Rat monoclonal)</td><td align="left" valign="bottom">R&amp;D systems</td><td align="left" valign="bottom">FAB5994A</td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NRP2 (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">3366; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2155250">AB_2155250</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NRP2-APC (Mouse monoclonal)</td><td align="left" valign="bottom">R&amp;D systems</td><td align="left" valign="bottom">FAB22151A; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10973479">AB_10973479</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Sca-1-PE (Rat monoclonal)</td><td align="left" valign="bottom">eBiosciences</td><td align="left" valign="bottom">12-5981-81; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_466085">AB_466085</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-integrin a7-biotin (Mouse monoclonal)</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="left" valign="bottom">130-101-979; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2652472">AB_2652472</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IgG-APC (Mouse)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">PA5-33237; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2550652">AB_2550652</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IgG-APC (Rat)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">17-4321-81; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_470181">AB_470181</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-MyHC (Mouse monoclonal)</td><td align="left" valign="bottom">Developmental Study Hybridoma Bank</td><td align="left" valign="bottom">MF-20; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2147781">AB_2147781</ext-link></td><td align="char" char="." valign="bottom">1:50</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-MyoD (Mouse monoclonal)</td><td align="left" valign="bottom">DAKO</td><td align="left" valign="bottom">M3512; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2148874">AB_2148874</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Pax7 (Mouse monoclonal)</td><td align="left" valign="bottom">Developmental Study Hybridoma Bank</td><td align="left" valign="bottom">PAX7; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_528428">AB_528428</ext-link></td><td align="char" char="." valign="bottom">1:20</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-pAKT (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">4060; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2315049">AB_2315049</ext-link></td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-VEGFA (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab52917; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_883427">AB_883427</ext-link></td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG Alexa488</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A-11001; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534069">AB_2534069</ext-link></td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rat IgG Alexa488</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A-11006; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_141373">AB_141373</ext-link></td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG Alexa488</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A-11008; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_143165">AB_143165</ext-link></td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG Alexa568</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A-11011; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_143157">AB_143157</ext-link></td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG Alexa568</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A-11004; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534072">AB_2534072</ext-link></td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rat IgG Alexa568</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A-11077; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534121">AB_2534121</ext-link></td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-biotin beads</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="left" valign="bottom">130-090-485; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_244365">AB_244365</ext-link></td><td align="left" valign="bottom">MACS (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PE beads</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="left" valign="bottom">130-048-801; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_244373">AB_244373</ext-link></td><td align="left" valign="bottom">MACS (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Activated Caspase-3</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab214430; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2938798">AB_2938798</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phosphoAKT1</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">4060; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2315049">AB_2315049</ext-link></td><td align="left" valign="bottom">1:200 for IHC, 1:1000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GAPDH HRP conjugated</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">3683; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1642205">AB_1642205</ext-link></td><td align="char" char="." valign="bottom">1:10000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-eMHC (Mouse monoclonal)</td><td align="left" valign="bottom">Developmental Study Hybridoma Bank</td><td align="left" valign="bottom">F1.652; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_528358">AB_528358</ext-link></td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Laminin-2 (Rat monoclonal)</td><td align="left" valign="bottom">MilliporeSigma</td><td align="left" valign="bottom">L0663; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477153">AB_477153</ext-link></td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">TTAAACGAACGTACTTGCAGATG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Vegfa 92 bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">AGAGGTCTGGTTCCCGAAA</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Vegfa 92 bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">GCAGAGCCAGGAACATATACACA</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR mFlt1 103 bp(Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">GAGATCCGAGAGAAAATGGCCTTT</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR mFlt1 103 bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">GCAGAGCCAGGAACATATACACA</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR sFlt1 73 bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CAGTGCTCACCTCTAACG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR sFlt1 73 bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CAGTGGTACTGGCAGCTAGAAG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR KDR/Flk1 66 bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">ACAAGCATACGGGCTTGTTT</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR KDR/Flk1 66 bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">TCCTGGGAAACTGGTATATCTATGA</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Nrp1 75 bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CATTCCAGAGCAAGGATAATCTG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Nrp1 75 bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">ATGGCTGGACACCCAATTT</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Nrp2 67 bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">ATGGTTAGGAAGCGCAGGT</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Nrp2 67 bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CACCTGGAGAGGATGAAGAAGAA</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Myh3 298 bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">AAGACTTGACTTTCACTTGGAGTTTA</named-content> TC</td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Myh3 298 bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">TTCGGAAGCTCCTTCTGTTT</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Htatsf1 79 bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CCAGAGTCTGAATACAATGGTCA</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR Htatsf1 79 bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CGCACGGCCGGTACAGTGAAACTG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR 18 S rRNA 343 bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CGCACGGCCGGTACAGTGAAACTG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">qPCR 18 S rRNA 343 bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CTTGCTCACCATGGTCAGCTGCTG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotyping Myh3 Exon1 WT/MUT-103bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CACTTTTAACTTCGACCCTGAGCC</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotyping Myh3 Exon2 WT/MUT-103bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">GGCCAGACTCTCTTTCTCAAGTGC</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotyping Myh3 Exon2 WT-135bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">GCAGAATTGCCTGTTATCCCTCCC</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotyping Myh3 Exon3 WT-135bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">GCTGCTGTTGATTACCTGGC</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotyping Pax7CreERT2 (Common)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CAAAAGACGGCAATATGGTG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying Pax7CreERT2 MUT-235bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CTGCACTGAGACAGGACCG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying Pax7CreERT2 WT-419bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">GGCATTAAAGCAGCGTATCC</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying R26RtdT (9103) MUT-196bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CTGTTCCTGTACGGCATGG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying R26RtdT (9105) MUT-196bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">AAGGGAGCTGCAGTGGAGTA</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying R26RtdT (9020) WT-297bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CCGAAAATCTGTGGGAAGTC</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying R26RtdT (9021) WT-297bp (Reserve)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">AGCAGCACGACTTCTTCAAGTCCG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying Flk1GFP-161bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CTCCTTGAAGTCGATGCCCTTCAG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying Flk1GFP-161bp (Reserve)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CGCTTTTTGTCAGTCATCTTCA</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying Flt1Loxp/Loxp (FlpeEX3F) WT-223bp/MUT-641bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">GTGCCACTGACCTAACATGTAAGAG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotying Flt1Loxp/Loxp (FlpeInt3R) WT-223bp/MUT-641bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom">CCA TAG ATG TGA CAA GCC AAG</td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotyping VEGFAHyper (24286) WT-254bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom">ACC CGG GGA TCC TCT AGA AC</td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotyping VEGFAHyper (25307) MUT-199bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom">GAC CGT GCT TGG TCA CCT</td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Genotyping VEGFAHyper (25308, Common) WT-254bp/MUT-199bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">CCTGGCCCTCAAGTACACCTT</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">VEGFALoxP/LoxP (muVEGF 419 .F) WT-106bp/MUT-148bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">TCCGTACGACGCATTTCTAG</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">VEGFALoxP/LoxP (muVEGF 567 .R) WT-106bp/MUT-148bp (Reverse)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">GAAGCTCCCAGAGACAAGTC</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">mdx5cv (0981) WT/MUT-180bp (Forward)</td></tr><tr><td align="left" valign="top">Sequence-based reagent (Oligo DNA)</td><td align="left" valign="bottom"><named-content content-type="sequence">TCATGAGCATGAAACTGTTCTT</named-content></td><td align="left" valign="bottom">Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">mdx5cv (0981) WT/MUT-180bp (Reverse)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">GoTaq qPCR Master Mix</td><td align="left" valign="bottom">Promega,</td><td align="left" valign="bottom">A6002</td><td align="left" valign="bottom">qPCR</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Click-iT EdU Alexa Fluor 488 Imaging Kit</td><td align="left" valign="bottom">Thermo Scientific</td><td align="left" valign="bottom">C10337</td><td align="left" valign="bottom">EdU staining</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Crystal violet Assay Kit</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab232855</td><td align="left" valign="bottom">Cell viability assay</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Transcriptor First Strand cDNA Synthesis Kit</td><td align="left" valign="bottom">Roche-Sigma-Aldrich</td><td align="char" char="." valign="bottom">4379012001</td><td align="left" valign="bottom">cDNA synthesis</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Annexin V-Biotin Apoptosis Detection Kit</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">BMS500BT-100</td><td align="left" valign="bottom">Appotosis assay</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">DirectZolTM RNA Microprep Kit</td><td align="left" valign="bottom">Zymo Research</td><td align="left" valign="bottom">R2062</td><td align="left" valign="bottom">RNA isolation</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Midi Fast Ion Plasmid Kit</td><td align="left" valign="bottom">IBI Scientific</td><td align="left" valign="bottom">IB47111</td><td align="left" valign="bottom">Plasmid DNA isolation</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">H&amp;E Staining Kit</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab245880</td><td align="left" valign="bottom">Histology</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SuperSignal West Femto chemiluminescent substrate</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">PI37074</td><td align="left" valign="bottom">Western Blotting</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NE-PER Nuclear and Cytoplasmic Extraction reagents</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">78833</td><td align="left" valign="bottom">Protein extraction</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">bFGF</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">PHG0263</td><td align="left" valign="bottom">MuSC culture (20 ng/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bovine serum albumin (BSA)</td><td align="left" valign="bottom">Jackson Immuno<break/>Research</td><td align="char" char="." valign="bottom">10001620</td><td align="left" valign="bottom">FACS/Immunostaining (1–2%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Chicken embryo extract</td><td align="left" valign="bottom">MP-Biomedical</td><td align="char" char="." valign="bottom">92850145</td><td align="left" valign="bottom">Single muscle fiber culture (0.5%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagen</td><td align="left" valign="bottom">BD Biosciences</td><td align="char" char="." valign="bottom">354236</td><td align="left" valign="bottom">Culture dish coating (0.01%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagenase type I</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C0130</td><td align="left" valign="bottom">Single myofiber isolation (0.2%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagenase type II</td><td align="left" valign="bottom">Worthington Biochemical Corp</td><td align="left" valign="bottom">CLD-2</td><td align="left" valign="bottom">FACS and MuSC/ES isolation (0.2%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DAPI (4’,6-diamidino-2-phenylindole dihydrochloride)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">D1306</td><td align="left" valign="bottom">DNA staining (1 µg/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dulbecco’s Modified Eagle’s Medium (DMEM)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">41966</td><td align="left" valign="bottom">Single myofiber and ES culture</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EdU</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">C10340</td><td align="left" valign="bottom">Cell proliferation (1 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">F-10 Ham's media</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">N6635</td><td align="left" valign="bottom">MuSC culture</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fetal calf serum (FCS)</td><td align="left" valign="bottom">Atlas Biological</td><td align="left" valign="bottom">FS-0500-AD</td><td align="left" valign="bottom">MuSC/EC/Single muscle fiber culture (10% or 20%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Horse serum</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">26050088</td><td align="left" valign="bottom">2% (coating), 5% (Differentiation culture)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">L-glutamine</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">25030</td><td align="left" valign="bottom">Culture medium (20 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Matrigel</td><td align="left" valign="bottom">Corning Life Sciences</td><td align="char" char="." valign="bottom">354230</td><td align="left" valign="bottom">Single muscle fiber culture (1:20)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Penicillin/streptomycin</td><td align="left" valign="bottom">Life Technologies</td><td align="char" char="." valign="bottom">15140</td><td align="left" valign="bottom">Culture medium (1 X)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tamoxifen (TMX)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">T5648</td><td align="left" valign="bottom">Cre recombinase (60 mg/kg i.p.)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">4-hydroxy tamoxifen (4-OHT)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">H6278</td><td align="left" valign="bottom">Culture (1 µM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cardiotoxin (CTX)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">V9125</td><td align="left" valign="bottom">Muscle injury (10 µM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DraIII</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">R3510S</td><td align="left" valign="bottom">DNA digestion (500 U/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ZombieNIR</td><td align="left" valign="bottom">Biolegends</td><td align="char" char="." valign="bottom">423105</td><td align="left" valign="bottom">FACS (0.1%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">recombinant VEGFA</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="char" char="." valign="bottom">493 MV</td><td align="left" valign="bottom">Culture (2–100 ng/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Thapsigargin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">T9033</td><td align="left" valign="bottom">Culture (1 µM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FLT1-FC</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="char" char="hyphen" valign="bottom">7756-FL</td><td align="left" valign="bottom">Culture (100 ng/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ZM306416</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="char" char="." valign="bottom">2499/1</td><td align="left" valign="bottom">Culture (3 µM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SU5402</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="char" char="." valign="bottom">3300/1</td><td align="left" valign="bottom">Culture (10 µM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EG00229</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="char" char="." valign="bottom">6986/10</td><td align="left" valign="bottom">Culture (30 µM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">PolyJet transfection reagent</td><td align="left" valign="bottom">Signagen Laboratories</td><td align="left" valign="bottom">SL100688</td><td align="left" valign="bottom">DNA transfection (10 µl for 6 cm plate)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Polybrene</td><td align="left" valign="bottom">MilliporeSigma</td><td align="left" valign="bottom">H9268</td><td align="left" valign="bottom">Viral infection (0.8 μg/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Saponin</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">ICN10285525</td><td align="left" valign="bottom">Immunostaining (0.01%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Direct Red 80</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="char" char="." valign="bottom">365548</td><td align="left" valign="bottom">Histology (0.1%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Proteinase K</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">P2308</td><td align="left" valign="bottom">DNA isolation (40 µg/mL)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Oil Red O solution</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">O1391-250ML</td><td align="left" valign="bottom">Histology (0.5%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Trizol</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="char" char="." valign="bottom">15596026</td><td align="left" valign="bottom">RNA isolation</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Photoshop 2020</td><td align="left" valign="bottom">Adobe</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.adobe.com/products/photoshop.html">https://www.adobe.com/products/photoshop.html</ext-link></td><td align="left" valign="bottom">Imaging analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/software/fiji/">https://imagej.net/software/fiji/</ext-link></td><td align="left" valign="bottom">Imaging analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">cellSens Entry 1.11</td><td align="left" valign="bottom">Olympus</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.olympus-lifescience.com/en/software/cellsens/">https://www.olympus-lifescience.com/en/software/cellsens/</ext-link></td><td align="left" valign="bottom">Microscopy</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism 9</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/support/faq/prism-900-release-notes/">https://www.graphpad.com/support/faq/prism-900-release-notes/</ext-link></td><td align="left" valign="bottom">Data analysis and statistics</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RStudio</td><td align="left" valign="bottom">RStudio</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.rstudio.com">https://www.rstudio.com</ext-link></td><td align="left" valign="bottom">Data analysis and statistics</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Autodesk Graphic</td><td align="left" valign="bottom">Autodesk</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphic.com">https://www.graphic.com</ext-link></td><td align="left" valign="bottom">Vector design</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">BioRender: Scientific Image and Illustration Software</td><td align="left" valign="bottom">BioRender.com</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.biorender.com">https://www.biorender.com</ext-link></td><td align="left" valign="bottom">Illustrator</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Anti-biotin beads</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="left" valign="bottom">130-090-485; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_244365">AB_244365</ext-link></td><td align="left" valign="bottom">MACS</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Anti-PE beads</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="left" valign="bottom">130-048-801; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_244373">AB_244373</ext-link></td><td align="left" valign="bottom">MACS</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Cell culture plate, 24 well</td><td align="left" valign="bottom">Sarstedt</td><td align="char" char="." valign="bottom">83.3922</td><td align="left" valign="bottom">Single myofiber culture</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Tissue culture dish</td><td align="left" valign="bottom">Sarstedt</td><td align="char" char="." valign="bottom">83.39</td><td align="left" valign="bottom">MuSC/ES culture</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Tissue culture dish</td><td align="left" valign="bottom">Sarstedt</td><td align="char" char="." valign="bottom">83.3901</td><td align="left" valign="bottom">MuSC/ES culture</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Tissue culture dish</td><td align="left" valign="bottom">Sarstedt</td><td align="char" char="." valign="bottom">83.3902</td><td align="left" valign="bottom">MuSC/ES culture</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">LD column</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="char" char="hyphen" valign="bottom">130-042-901</td><td align="left" valign="bottom">MACS</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">MS column</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="char" char="hyphen" valign="bottom">130-042-201</td><td align="left" valign="bottom">MACS</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Fortessa X-20</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom"/><td align="left" valign="bottom">FACS</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">BD FACSAria</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom"/><td align="left" valign="bottom">FACS</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">moorLabTM laser Doppler</td><td align="left" valign="bottom">Moor Instruments</td><td align="left" valign="bottom">MOORVMS-LDF</td><td align="left" valign="bottom">Laser Doppler flow</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Grip strength meter</td><td align="left" valign="bottom">Columbus Instruments</td><td align="char" char="hyphen" valign="bottom">1027CSM-D54</td><td align="left" valign="bottom">Forelimb muscle force</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">iBright FL1500</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A44115</td><td align="left" valign="bottom">Western blotting</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Olympus IX81 Inverted Fluorescense microscope</td><td align="left" valign="bottom">Olympus</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Microscope</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Olympus BX51 Fluorescense microscope</td><td align="left" valign="bottom">Olympus</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Microscope</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73592.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cheung</surname><given-names>Tom H</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00q4vv597</institution-id><institution>The Hong Kong University of Science and Technology</institution></institution-wrap><country>Hong Kong</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.08.28.458037" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.28.458037"/></front-stub><body><p>This study presents a valuable finding on the unique role of VEGFA-FLT1-AKT1 signaling in regulating muscle stem cell (MuSC) survival. The evidence supporting the claims is convincing, with multiple approaches utilized, including pharmacological and genetic methods performed in vitro and in vivo, demonstrating that the VEGFA-FLT1-AKT1 axis protected MuSCs from apoptosis. The work will be of broad interest to researchers in the MuSC biology field and support the future development of VEGFA and FLT1 targeted therapies for various diseases, such as cancer and neuromuscular diseases.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73592.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cheung</surname><given-names>Tom H</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00q4vv597</institution-id><institution>The Hong Kong University of Science and Technology</institution></institution-wrap><country>Hong Kong</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Saverio Tedesco</surname><given-names>Francesco</given-names></name><role>Reviewer</role></contrib><contrib contrib-type="reviewer"><name><surname>Kuang</surname><given-names>Shihuan</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>Purdue University West Lafayette</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.28.458037">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.08.28.458037v2">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Kathryn Cheah as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Francesco Saverio Tedesco (Reviewer #2); Shihuan Kuang (Reviewer #4).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions (for the authors):</p><p>(1) Using exogenous and blocking VEGFA in vitro improves or inhibits survival, respectively, and in vivo experiments support the notion of cell- autonomous function of VEGFA in SCs. Nevertheless, it is intriguing that VEGFA had no effects on cell survival in response to ER-stress. Did the authors test different concentrations of VEGFA or test if VEGFA in the culture serum or secreted from cultured myoblasts is sufficient to protect ER-stress induced apoptosis?</p><p>(2) Some discussion points should be addressed. First, the potential redundant and distinct functions of signaling through FLT1 and FLK1 should be addressed. Is VEGFA signaling through these receptors dose dependent or dependent on the co-receptors? What is the effect of exogenous VEGFA on VEGFA-KO SCs? Can the authors add VEGFA in vitro to the KO SCs to determine if there is a threshold level that FLT1-decoy mediates that may be important to exert the cell-autonomous effect.</p><p>(3) The authors also analyzed publicly available datasets to show that Vegfa expression is reduced in skeletal muscles of DMD patients and animal models. Furthermore, deletion of Flt1 in mdx aggravates, whereas Vegfa overexpression ameliorates muscle pathology. This conclusion could be consolidated by explaining or investigating why Vegfa expression is reduced in dystrophic muscle? For example, is it due reduced MuSCs as they are the main source of VEGFA? Please expand the discussion on whether the improved phenotype is mainly due to improved satellite cell survival or due to improved vascular differentiation or function in response to Vegfa overexpression. Is there any evidence that satellite cell survival is impaired in mice with myopathies, and if survival is improved in the VEGFA+/Hyper/mdx mice relative to mdx mice? Please provide some evidence to support that (i) satellite cell survival is impaired in mdx mice, and (ii) activation of VEGFA signaling improves survival of satellite cells in the mdx mice. This in vivo data would better justify the main conclusion of the study.</p><p>(4) Figure 2H: phospho-Akt should be quantified via a more quantitative method such as western blot.</p><p>(5) Figure 3 While in the manuscript muscle, it is claimed that muscle injury has been induced by BaCl2, in the figure it is mentioned that muscle injury has been induced by CTX. Please clarify.</p><p>(6) Figure 3B: The representative HandE staining pictures shown for VEGFA+/+ and VEGFA+/hyper show inflammatory cell infiltration (accumulation of nuclei between myocytes). What about muscle inflammation in your models. Inflammatory cells are also a big source of VEGFA in injured skeletal muscle.</p><p>(7) Figure 3D How are Musc quantified?</p><p>8) Figure 3E, F How is ferret diameter measured?</p><p>(9) Figure 3G How is Anexin 5 staining quantified? Do the histograms show total Anexin 5+ cells or only double Pax7+/Anexin 5+ cells?</p><p>(10) Figure 4, the authors should quantify capillary density to strengthen their laser blood flow data.</p><p>(11) Figure 4G and 4J legends and figure panels do not seem to correspond.</p><p>(12) Since the authors used Pax7tdT mice they should be able to track the fate of VegfA+/Hyper, VegfaKO or Flt1KO satelite cells upon injury and to quantify the number and/or percentage of tomato+ myocytes after injury in each model reflecting the specific consequences of impaired VEGFA signaling in satellite cells.</p><p>(13) Supp Figure 3 How was muscle injury induced what injury</p><p>(14) Sup Figure 3F is poorly representative, myocyte seem to be larger in MuSC-VEGFA KO mice mice.</p><p>(15) Line 180-182: VEGFA is repeated, and the sentence should be rewritten.</p><p>(16) Standard convention for protein and gene name should be used throughout the study. For example, VEGFA should be used for the protein and Vegfa (italic) should be used for the gene and mRNA.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73592.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions (for the authors):</p><p>(1) Using exogenous and blocking VEGFA in vitro improves or inhibits survival, respectively, and in vivo experiments support the notion of cell- autonomous function of VEGFA in SCs. Nevertheless, it is intriguing that VEGFA had no effects on cell survival in response to ER-stress. Did the authors test different concentrations of VEGFA or test if VEGFA in the culture serum or secreted from cultured myoblasts is sufficient to protect ER-stress induced apoptosis?</p></disp-quote><p>Thanks for pointing out that this aspect needed to be clarified. VEGFA in fetal bovine serum (FBS) is expected to be in the femtogram range, so we do not expect it to be a significant contributing factor. Since myoblasts themselves secrete a high amount of VEGFA, we think that endogenous VEGFA may be responsible for the lack of exogenous effect of VEGFA in the absence of other inhibitors. There are reports of intracellular VEGFA having a distinct role in cell survival (Lee et al., 2007). Our data further supports this, which shows that <italic>Vegfa</italic>-KO MuSCs are exquisitely sensitive to apoptosis after injury (Figure 3G). In addition, we tried a dose escalation of VEGFA. We did see improved cell survival in myoblast following UV light-induced apoptosis at 20 ng/ml compared to 50 ng/ml (Figure 2—figure supplement 1E and 1F). This makes biological sense as the concentration of VEGFA has distinct downstream effects (Noren et al., 2016).</p><p>Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML. 2007. Autocrine VEGF signaling is required for vascular homeostasis. <italic>Cell</italic> 130:691–703. doi:10.1016/j.cell.2007.06.054</p><p>Noren DP, Chou WH, Lee SH, Qutub AA, Warmflash A, Wagner DS, Popel AS, Levchenko A. 2016. Endothelial cells decode VEGF-mediated ca<sup>2+</sup> signaling patterns to produce distinct functional responses. <italic>Sci Signal</italic> 9:ra20–ra20. doi:10.1126/scisignal.aad3188</p><disp-quote content-type="editor-comment"><p>(2) Some discussion points should be addressed. First, the potential redundant and distinct functions of signaling through FLT1 and FLK1 should be addressed. Is VEGFA signaling through these receptors dose dependent or dependent on the co-receptors? What is the effect of exogenous VEGFA on VEGFA-KO SCs? Can the authors add VEGFA in vitro to the KO SCs to determine if there is a threshold level that FLT1-decoy mediates that may be important to exert the cell-autonomous effect.</p></disp-quote><p>The differential functions of VEGFA on FLT1 and FLK1 in MuSC are indeed exciting. During the review of this paper, two groups have either published (Groppa et al., 2023) or submitted a pre-print (Chen et al., 2022) complementing this work. While FLK1 was not the focus of our report, both these reports have performed extensive experiments on the role of FLK1 in proliferation. The discussion regarding these reports and how they complement our report has been added to the Discussion section. The endogenous vs exogenous VEGFA is a complicated system currently under investigation but is outside the scope of this current report.</p><p>Regarding co-receptors' effect, KDR (FLK1) works with its co-receptor NRP1. We investigated the inhibition of NRP1 using the pharmacological inhibitor EG00229, which is an NRP1 receptor antagonist for VEGFA and does not affect VEGFA binding to FLT1 of KDR1. We found no effect of NRP1 inhibition on cell survival in vitro. This experiment can be found in Figure 2C and 2D.</p><p>Chen W, Wang YX, Ritso M, Perkins TJ, Rudnicki MA. 2022. KDR Signaling in Muscle Stem Cells Promotes Asymmetric Division and Progenitor Generation for Efficient Regeneration. bioRxiv. 2022.06.27.497734. doi: https://doi.org/10.1101/2022.06.27.497734</p><p>Groppa E, Martini P, Derakhshan N, Theret M, Ritso M, Tung LW, Wang YX, Soliman H, Hamer MS, Stankiewicz L, Eisner C, Erwan LN, Chang C, Yi L, Yuan JH, Kong S, Weng C, Adams J, Chang L, Peng A, Blau HM, Romualdi C, Rossi FMV. 2023. Spatial compartmentalization of signaling imparts source-specific functions on secreted factors. <italic>Cell Rep.</italic> 42:112051. doi: 10.1016/j.celrep.2023.112051</p><disp-quote content-type="editor-comment"><p>(3) The authors also analyzed publicly available datasets to show that Vegfa expression is reduced in skeletal muscles of DMD patients and animal models. Furthermore, deletion of Flt1 in mdx aggravates, whereas Vegfa overexpression ameliorates muscle pathology. This conclusion could be consolidated by explaining or investigating why Vegfa expression is reduced in dystrophic muscle? For example, is it due reduced MuSCs as they are the main source of VEGFA? Please expand the discussion on whether the improved phenotype is mainly due to improved satellite cell survival or due to improved vascular differentiation or function in response to Vegfa overexpression. Is there any evidence that satellite cell survival is impaired in mice with myopathies, and if survival is improved in the VEGFA+/Hyper/mdx mice relative to mdx mice? Please provide some evidence to support that (i) satellite cell survival is impaired in mdx mice, and (ii) activation of VEGFA signaling improves survival of satellite cells in the mdx mice. This in vivo data would better justify the main conclusion of the study.</p></disp-quote><p>We divided comment five into individual portions to better address them as below.</p><disp-quote content-type="editor-comment"><p>“The authors also analyzed publicly available datasets to show that Vegfa expression is reduced in skeletal muscles of DMD patients and animal models. Furthermore, deletion of Flt1 in mdx aggravates, whereas Vegfa overexpression ameliorates muscle pathology.”</p></disp-quote><p>We have investigated several aspects of FLT1 biology in the <italic>mdx</italic> mice, so we would like to clarify the point about the deletion of <italic>Flt1</italic> in <italic>mdx</italic> mice. While complete knockout of <italic>Flt1</italic> is embryonic lethal, haploinsufficient <italic>Flt1</italic> (<italic>Flt1</italic> heterozygous KO) in the <italic>mdx</italic> background rescues the dystrophic pathology via increased vascular density since FLT1 acts as a decoy receptor and a sink trap for VEGF thereby, preventing excessive normal and pathological angiogenesis (Verma et al., 2010). This can be phenocopied by conditional deletion of <italic>Flt1</italic> in the endothelial cells and with drugs targeting Flt1 (Verma et al., 2019; Bosco et al., 2021). Deletion of <italic>Flt1</italic> in MuSCs does worsen the phenotype in the <italic>mdx</italic> mice. This is an example of the complicated cell type-specific response that can interplay in muscle regeneration concerning VEGFA and its receptors.</p><p>Verma M, Asakura Y, Hirai H, Watanabe S, Tastad C, Fong G-H, Ema M, Call JA, Lowe DA, Asakura A. 2010. Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice. Hum Mol Genet 19:4145–59. doi:10.1093/hmg/ddq334</p><p>Verma M, Shimizu-Motohashi Y, Asakura Y, Ennen JP, Bosco J, Zhou Z, Fong G, Josiah S, Keefe D, Asakura A. 2019. Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy. PLOS Genet 15:e1008468. doi:10.1371/journal.pgen.1008468</p><p>Bosco J, Zhou Z, Gabriëls S, Verma M, Liu N, Miller BK, Gu S, Lundberg DM, Huang Y, Brown E, Josiah S, Meiyappan M, Traylor MJ, Chen N, Asakura A, De Jonge N, Blanchetot C, de Haard H, Duffy HS, Keefe D. 2021. VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy.</p><disp-quote content-type="editor-comment"><p>“This conclusion could be consolidated by explaining or investigating why Vegfa expression is reduced in dystrophic muscle? For example, is it due reduced MuSCs as they are the main source of VEGFA?”</p></disp-quote><p>While MuSCs are a large contributor to VEGFA by cell volume (Verma et al., 2018), the muscle fiber is expected to secrete the most VEGFA, given its disproportionately large volume (Mac Gabhann et al., 2011). We suspect that the VEGFA is reduced in the progressive dystrophic muscle due to these diseases' loss of muscle mass. In addition, the reported RNA-seq data also confirmed the down-regulation of <italic>Vegfa</italic> in DMD and BMD patients, as well as in DMD model dogs and mice, as shown in Figure 4—figure supplement 1A.</p><p>Verma M, Asakura Y, Murakonda BSR, Pengo T, Latroche C, Chazaud B, McLoon LK, Asakura A. 2018. Muscle Satellite Cell Cross-Talk with a Vascular Niche Maintains Quiescence via VEGF and Notch Signaling. Cell Stem Cell 23:530-543.e9. doi:10.1016/j.stem.2018.09.007</p><p>Mac Gabhann F, Qutub AA, Annex BH, Popel AS. 2011. Systems biology of proangiogenic therapies targeting the VEGF system. Wiley Interdiscip Rev Syst Biol Med 2:694–707. doi:10.1002/wsbm.92</p><disp-quote content-type="editor-comment"><p>“Please expand the discussion on whether the improved phenotype is mainly due to improved satellite cell survival or due to improved vascular differentiation or function in response to Vegfa overexpression. Is there any evidence that satellite cell survival is impaired in mice with myopathies, and if survival is improved in the VEGFA+/Hyper/mdx mice relative to mdx mice?”</p></disp-quote><p>Our goal with the current project was to answer the question stated above whether the improved pathology seen in the <italic>mdx</italic> mouse by indirect increase in VEGFA (via modulation of FLT1) was due to its effect on the vasculature or the MuSC (Verma et al., 2010; Verma et al., 2019; Bosco et al., 2021). By deleting the <italic>Flt1</italic> in the MuSC specifically, we were expecting to decouple the vascular contribution from the MuSC contribution. However, as shown in Figure 4B and Supplemental Figure 4-1D, conditional knockout of <italic>Flt1</italic> in MuSC decreases the capillary density, thus making it difficult to delineate between the two mechanisms of action with the current set of experiments.</p><disp-quote content-type="editor-comment"><p>“Please provide some evidence to support that (i) satellite cell survival is impaired in mdx mice”</p></disp-quote><p>evidence that MuSC survival is impaired comes indirectly from transplantation experiments where satellite cells obtained from <italic>mdx</italic> mice engraft much less than those from WT mice (Boldrin et al., 2015). This sentence was included in the Discussion section.</p><disp-quote content-type="editor-comment"><p>&quot; (ii) activation of VEGFA signaling improves survival of satellite cells in the mdx mice”</p></disp-quote><p>Thank you for recommending this experiment. We performed the specific experiment that was requested. We used the Pax7 lineage tdTomato reporter mice crossed into the mdx mice and the <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> allele to yield <italic>mdx:Vegfa<sup>+/+</sup>:Pax7<sup>tdT</sup></italic> and <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup><italic>:Pax7<sup>tdT</sup></italic> mice. We injected BaCl<sub>2</sub> to create acute TA muscle injury, and the muscle section was stained for activated Caspase-3 (Cas-3) as a marker for apoptotic cell death 72 hrs after the injury. We detected decreased Cas-3(+)tdTomato(+) apoptotic MuSCs in the <italic>Vegfa<sup>+/</sup></italic><sup>Hyper</sup> allele compared with <italic>Vegfa<sup>+/+</sup></italic> allele, indicating that increased VEGFA improves MuSC survival in the <italic>mdx</italic> mice in vivo. These data are now in the new Figure 4—figure supplement 2A-2C. A similar experiment was performed by Gropa et al. during the review process (Groppa et al., 2023). They evaluated TUNEL(+)MyoD(+) cells in muscle after NTX injury and found them to be elevated in the MuSC<italic>Vegfa</italic>-cKO muscle. Lastly, this data also comes from extrapolation of data from MuSC transplantation studies where VEGFA over-expression in either the MuSC or the host muscle improved the survival of the transplanted cells (Bouchentouf et al., 2008).</p><p>Bouchentouf M, Benabdallah BF, Bigey P, Yau TM, Scherman D, Tremblay JP. 2008. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther 15:404–414.</p><p>Groppa E, Martini P, Derakhshan N, Theret M, Ritso M, Tung LW, Wang YX, Soliman H, Hamer MS, Stankiewicz L, Eisner C, Erwan LN, Chang C, Yi L, Yuan JH, Kong S, Weng C, Adams J, Chang L, Peng A, Blau HM, Romualdi C, Rossi FMV. 2023. Spatial compartmentalization of signaling imparts source-specific functions on secreted factors. Cell Rep. 42:112051. doi: 10.1016/j.celrep.2023.112051</p><disp-quote content-type="editor-comment"><p>(4) Figure 2H: phospho-Akt should be quantified via a more quantitative method such as western blot.</p></disp-quote><p>We performed the western blotting and quantification as recommended, and the data is presented in new Figure 2—figure supplement 1N and 1O using an Imaging analyzer (iBright FL1500, ThermoFisher Scientific).</p><disp-quote content-type="editor-comment"><p>(5) Figure 3 While in the manuscript muscle, it is claimed that muscle injury has been induced by BaCl2, in the figure it is mentioned that muscle injury has been induced by CTX. Please clarify</p></disp-quote><p>Thank you for this indication. In the experiments shown in Figure 1, we utilized CTX to induce muscle injury, while in the experiments shown in Figure 3, we utilized BaCl<sub>2</sub> to induce muscle injury. We clarified the methods used for inducing muscle injury in the main text and figure legends.</p><disp-quote content-type="editor-comment"><p>(6) Figure 3B: The representative HandE staining pictures shown for VEGFA+/+ and VEGFA+/hyper show inflammatory cell infiltration (accumulation of nuclei between myocytes). What about muscle inflammation in your models. Inflammatory cells are also a big source of VEGFA in injured skeletal muscle.</p></disp-quote><p>We agree that inflammatory cells are a significant source of VEGFA, and this makes this biology complicated and out of the scope of the current report. However, this was recently touched on in a complimentary publication (Groppa et al., 2023), where they evaluated the expression of VEGFA in inflammatory at different times and also performed lineage-based deletion of <italic>VEGFA</italic> in all hematopoietic cells using the <italic>VAV-Cre</italic> mice. While the data was not shown in the paper, they mentioned that they found a reduction in vessel density and disrupted muscle regeneration in this mouse model.</p><p>Groppa E, Martini P, Derakhshan N, Theret M, Ritso M, Tung LW, Wang YX, Soliman H, Hamer MS, Stankiewicz L, Eisner C, Erwan LN, Chang C, Yi L, Yuan JH, Kong S, Weng C, Adams J, Chang L, Peng A, Blau HM, Romualdi C, Rossi FMV. 2023. Spatial compartmentalization of signaling imparts source-specific functions on secreted factors. Cell Rep. 42:112051. doi: 10.1016/j.celrep.2023.112051</p><disp-quote content-type="editor-comment"><p>(7) Figure 3D How are Musc quantified?</p></disp-quote><p>MuSCs are quantified by Pax7 immunofluorescence after single muscle fiber isolation, as reflected in the Figure 3 legend.</p><disp-quote content-type="editor-comment"><p>(8) Figure 3E, F How is ferret diameter measured?</p></disp-quote><p>Feret’s diameter was measured manually using ImageJ (FIJI), as mentioned in the Materials and methods section.</p><disp-quote content-type="editor-comment"><p>(9) Figure 3G How is Anexin 5 staining quantified? Do the histograms show total Anexin 5+ cells or only double Pax7+/Anexin 5+ cells?</p></disp-quote><p>We utilized FACS analysis to quantify Annexin V(+/-) MuSCs. This histogram in Figure 3G shows the populations of Pax7-tdTomato(+)Annexin V(-) live MuSCs and Pax7tdTomato(+)Annexin V(+) apoptotic MuSCs.</p><disp-quote content-type="editor-comment"><p>(10) Figure 4, the authors should quantify capillary density to strengthen their laser blood flow data.</p></disp-quote><p>The CD31(+) capillary densities from the <italic>mdx:MuSC-Flt1<sup>Δ/Δ</sup></italic> and <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice have been performed and are shown in the new Figure 4B and 4G, and Figure 4—figure supplement 1D. As a result, the capillary densities in the <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mice and <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice are decreased and increased, respectively. This is consistent with the laser Doppler flow data for the <italic>mdx:</italic>MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mice (decreased; Figure 4E) and <italic>mdx:Vegfa<sup>+/</sup></italic><sup>Hyper</sup> mice (increased; Figure 4J).</p><disp-quote content-type="editor-comment"><p>(11) Figure 4G and 4J legends and figure panels do not seem to correspond</p></disp-quote><p>Thank you for bringing this to our attention. We have changed both figure legends.</p><disp-quote content-type="editor-comment"><p>(12) Since the authors used Pax7tdT mice they should be able to track the fate of VegfA+/Hyper, VegfaKO or Flt1KO satelite cells upon injury and to quantify the number and/or percentage of tomato+ myocytes after injury in each model reflecting the specific consequences of impaired VEGFA signaling in satellite cells.</p></disp-quote><p>When the <italic>Pax7<sup>tdT</sup></italic> mouse muscle is injured, we see a unanimous expression of tdTomato(+) in the muscle fibers in the damaged area, indicating that each muscle fiber that was injured had some contribution from the tdTomato(+) MuSC. We attempted to get around this predicament by looking at the muscle four days after injury. At this point, the muscle fibers are in the active phase of growth after injury, and the size of the muscle fiber could be used as a proxy for the amount of MuSC contribution. We quantified the maturity of the embryonic myosin heavy chain (eMHC)(+) fibers in MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic>, MuSC<italic>-Flt1<sup>Δ/Δ</sup>,</italic> and <italic>Vefgfa<sup>+/</sup></italic><sup>Hyper</sup> mice during regeneration. We noticed that in VEGFA+/Hyper mice, the eMHC(+) fibers were significantly more prominent, and reciprocally, the eMHC+ fibers in the MuSC<italic>-Vegfa<sup>Δ/Δ</sup></italic> and MuSC<italic>-Flt1<sup>Δ/Δ</sup></italic> mice were smaller (new Figure 3—figure supplement 1E and 1F). Since the fibers were not different in size at baseline (Figure 3B, 3F, 3J, and 3N), we can expect these changes to result from the MuSC contribution during regeneration.</p><disp-quote content-type="editor-comment"><p>(13) Supp Figure 3 How was muscle injury induced what injury.</p></disp-quote><p>Muscle injury was induced by intramuscular injection of BaCl<sub>2</sub>, as listed in Figure 3A.</p><disp-quote content-type="editor-comment"><p>(14) Sup Figure 3F is poorly representative, myocyte seem to be larger in MuSC-VEGFA KO mice mice.</p></disp-quote><p>Thank you for highlighting this. We have now put in more representative images in Figure 3—figure supplement 2B.</p><disp-quote content-type="editor-comment"><p>(15) Line 180-182: VEGFA is repeated, and the sentence should be rewritten.</p></disp-quote><p>We rewrote the sentence.</p><disp-quote content-type="editor-comment"><p>(16) Standard convention for protein and gene name should be used throughout the study. For example, VEGFA should be used for the protein and Vegfa (italic) should be used for the gene and mRNA.</p></disp-quote><p>Thank you for pointing this out. We have made the changes accordingly throughout the manuscript.</p></body></sub-article></article>